<SEC-DOCUMENT>0001683168-25-007700.txt : 20251021
<SEC-HEADER>0001683168-25-007700.hdr.sgml : 20251021
<ACCEPTANCE-DATETIME>20251021171841
ACCESSION NUMBER:		0001683168-25-007700
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20251020
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251021
DATE AS OF CHANGE:		20251021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kartoon Studios, Inc.
		CENTRAL INDEX KEY:			0001355848
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MOTION PICTURE & VIDEO TAPE PRODUCTION [7812]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				204118216
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37950
		FILM NUMBER:		251407974

	BUSINESS ADDRESS:	
		STREET 1:		190 N. CANON
		STREET 2:		4TH FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90210
		BUSINESS PHONE:		310-273-4222

	MAIL ADDRESS:	
		STREET 1:		190 N. CANON
		STREET 2:		4TH FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Genius Brands International, Inc.
		DATE OF NAME CHANGE:	20111109

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIFIC ENTERTAINMENT CORP
		DATE OF NAME CHANGE:	20060310
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>kartoon_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:TOON="http://gnusbrands.com/20251020">
<head>
     <title>KARTOON STUDIOS, INC. 8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_TOON_gnusbrands.com_20251020 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20251020_20251020 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001355848 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000004" name="dei:EntityCentralIndexKey">0001355848</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="toon-20251020.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-20</xbrli:startDate>
        <xbrli:endDate>2025-10-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>FORM <span id="xdx_903_edei--DocumentType_c20251020__20251020_zn6enknG8oT3"><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> Date of Report (Date of earliest event
reported): <b><span id="xdx_900_edei--DocumentPeriodEndDate_c20251020__20251020_zgS3rP8urFH7"><ix:nonNumeric contextRef="AsOf2025-10-20" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October 20, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_906_edei--EntityRegistrantName_c20251020__20251020_zg2yqxOCpm59" style="font-size: 12pt"><b><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000011" name="dei:EntityRegistrantName">KARTOON
STUDIOS, INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 36%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20251020__20251020_zJSHRLI8lanb"><ix:nonNumeric contextRef="AsOf2025-10-20" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction<br/>
    of incorporation or organization)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td>
    <td style="width: 28%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityFileNumber_c20251020__20251020_zuvhE3z7pXNa"><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000013" name="dei:EntityFileNumber">001-37950</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission File Number)</p></td>
    <td style="width: 36%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20251020__20251020_zU8c3oqgFDf"><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000014" name="dei:EntityTaxIdentificationNumber">20-4118216</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer Identification No.)</p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_904_edei--EntityAddressAddressLine1_c20251020__20251020_z9gVgWm59zK7"><b><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000015" name="dei:EntityAddressAddressLine1">190
N. Canon Drive, 4th Fl.</ix:nonNumeric></b></span>, <span id="xdx_903_edei--EntityAddressCityOrTown_c20251020__20251020_zI1SRyXuQXM"><b><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000016" name="dei:EntityAddressCityOrTown">Beverly
Hills</ix:nonNumeric></b></span><b>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20251020__20251020_zBb3qlMz7lv3"><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000017" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span></b> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20251020__20251020_z9yh3M3vkN1k"><b><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000018" name="dei:EntityAddressPostalZipCode">90210</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Address of principal executive
offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90A_edei--CityAreaCode_c20251020__20251020_zC8v64C7KwAk"><b><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000019" name="dei:CityAreaCode">(310)</ix:nonNumeric> </b></span><b><span id="xdx_900_edei--LocalPhoneNumber_c20251020__20251020_zHe6vONzNkdf"><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000020" name="dei:LocalPhoneNumber">273-4222</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Registrant&#8217;s telephone number, including area code</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--WrittenCommunications_c20251020__20251020_zFX7gGQLddb9"><ix:nonNumeric contextRef="AsOf2025-10-20" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--SolicitingMaterial_c20251020__20251020_zZi0JdbvEYRk"><ix:nonNumeric contextRef="AsOf2025-10-20" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--PreCommencementTenderOffer_c20251020__20251020_zOrBHQw0n9Xb"><ix:nonNumeric contextRef="AsOf2025-10-20" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20251020__20251020_z4aHYs9YaJUf"><ix:nonNumeric contextRef="AsOf2025-10-20" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 40%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="width: 20%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="width: 40%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--Security12bTitle_c20251020__20251020_zmQ0N2MRm4D9"><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000025" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--TradingSymbol_c20251020__20251020_zy3C1f9cWFMb"><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000026" name="dei:TradingSymbol">TOON</ix:nonNumeric></span></b></span></td>
    <td style="font-size: 10pt; text-align: center"><span id="xdx_906_edei--SecurityExchangeName_c20251020__20251020_zssSlyWKiNuh" style="font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-10-20" id="Fact000027" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric> </b></span><b><span style="font-size: 10pt">American
    LLC</span></b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20251020__20251020_zGK8anTJPJyf"><ix:nonNumeric contextRef="AsOf2025-10-20" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 1.01. Entry into
a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Registered Direct Offering and Concurrent Private
Placement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 20, 2025, Kartoon Studios, Inc. (the
&#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with an institutional investor
(the &#8220;Purchaser&#8221;), pursuant to which the Company agreed to issue to the Purchaser, (i) in a registered direct offering (the
&#8220;Registered Direct Offering&#8221;), 3,000,000 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value
$0.001 per share (the &#8220;Common Stock&#8221;), and pre-funded warrants (&#8220;Pre-Funded Warrants&#8221;) to purchase up to 6,903,049
shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;), and (ii) in a concurrent private placement (the &#8220;Concurrent
Private Placement&#8221;), common warrants (the &#8220;Common Warrants&#8221;) to purchase an aggregate of up to 9,903,049 shares of Common
Stock (the &#8220;Common Warrant Shares&#8221;), with an exercise price of $0.738. The Registered Direct Offering and the Concurrent Private
Placement are collectively referred to in this Current Report on Form 8-K (&#8220;Current Report&#8221;) as the &#8220;Offerings.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects the Offerings to close on
October 22, 2025, subject to the satisfaction of customary closing conditions (the &#8220;Closing Date&#8221;), and to receive aggregate
gross proceeds from the Offerings of approximately $7.3 million, excluding any proceeds that may be received upon the exercise of the
Common Warrants and before deducting placement agent fees and other offering expenses payable by the Company. Each Share and privately
placed Common Warrant will be sold at a public offering price of $0.738. Each Pre-Funded Warrant and privately placed Common Warrant will
be sold at a public offering price of $0.737. The Shares, Pre-Funded Warrants and Common Warrants will be issued separately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to use the net proceeds from
the Offering for working capital and general corporate purposes. This capital infusion will also provide funds for the global launch and
marketing of the upcoming animated series:<i>&#160;Hundred Acre Wood&#8217;s Winnie &amp; Friends</i>,&#160;and <i>Bitcoin Brigade</i>&#160;,
as well as the <i>Stan Lee Universe</i>&#160;expansion rollout, and ongoing growth and content acquisition for Kartoon Channel!&#8217;s
streaming service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shares, Pre-Funded Warrants and Pre-Funded
Warrant Shares are being offered by the Company pursuant to a shelf registration statement on Form S-3 (File No. 333-276259), which was
declared effective by the Securities and Exchange Commission (the &#8220;Commission&#8221;) on January 5, 2024 (the &#8220;Registration
Statement&#8221;). The Common Warrants and the Common Warrant Shares are being issued in the Concurrent Private Placement and have not
been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are instead being offered pursuant
to the exemption provided in Section 4(a)(2) under the Securities Act and/or Rule 506(b) promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the Purchase Agreement,
until January 31, 2026, the Company has agreed that neither it nor of its subsidiaries will issue (or enter into any agreement to issue)
any shares of Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement) or file any registration statement or any
amendment or supplement thereto, other than (i) the prospectus supplement relating to the Registered Direct Offering, (ii) the Resale
Registration Statement (as defined below), and (iii) certain limited exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has agreed, subject to limited exceptions,
for a period from the date of the Purchase Agreement until October 20, 2027, not to issue, enter into any agreement to issue or announce
the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement) involving
a Variable Rate Transaction (as defined in the Purchase Agreement), provided however that commencing October 20, 2026, the Company shall
be allowed to enter into, and issue shares pursuant to, an &#8220;at the market&#8221; offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dawson James Securities Inc. acted as the exclusive
placement agent (the &#8220;Placement Agent&#8221;) on a &#8220;reasonable best efforts&#8221; basis, in connection with the Offerings
pursuant to that certain letter agreement, dated October 18, 2025 (the &#8220;Engagement Agreement&#8221;), by and between the Company
and the Placement Agent. Pursuant to the Engagement Agreement, the Placement Agent will receive a cash fee of 7.0% of the aggregate gross
proceeds paid to the Company for the securities sold in the Offerings as well as 7.0% of the gross proceeds received from the exercise
of any Common Warrants and reimbursement of certain out-of-pocket expenses up to a maximum of $75,000. As additional compensation to the
Placement Agent, in connection with the Offerings, the Company will issue to the Placement Agent or its designees, warrants (the &#8220;Placement
Agent Warrants&#8221;) to purchase an aggregate of 693,213 shares of Common Stock (the &#8220;Placement Agent Warrant Shares&#8221;).
The Placement Agent Warrants have substantially the same terms as the Common Warrants, except that they have an exercise price per share
equal to $0.8118, which is equal to 110% of the public offering price per Share and privately placed Common Warrant. The Placement Agent
Warrants are being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and/or Rule 506(b) promulgated
thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, pursuant to the terms of the Engagement
Agreement: (i) the Company has granted the Placement Agent, subject to certain exceptions, a right of first refusal for a period of twelve&#160;(12)
months following the closing of the Offerings to act as the Company&#8217;s lead managing underwriter or book runner, or as lead placement
agent, for any and all future equity or equity-linked (including convertible debt) offerings during such twelve-month period, and (ii)
the Company has agreed to pay the Placement Agent a tail fee equal to the cash and warrant compensation in the Offerings, in connection
with any public or private offering or other financing or capital-raising transaction of any kind effected by the Company to the extent
that such financing or capital is provided to the Company by investors whom the Placement Agent had first introduced to the Company during
the term of the Engagement Letter or within the 12-month period following the expiration or termination of the Engagement Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Purchase Agreement, the Company
agreed to file, as soon as practicable (and in any event within thirty (30) calendar days of the date of the Purchase Agreement), a registration
statement on Form S-1 (or other appropriate form if the Company is not then S-1 eligible) (the &#8220;Resale Registration Statement&#8221;)
providing for the resale by the Purchaser of the Common Warrant Shares issuable upon exercise of the Common Warrants. In addition, the
Company will use commercially reasonable efforts to cause the Resale Registration Statement to become effective within ninety (90) days
following the Closing Date and to keep the Resale Registration Statement effective at all times until the Purchaser does not own any Common
Warrants or Common Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Purchase Agreement, the Purchaser
has the right to participate in certain subsequent financings by the Company in an amount equal to 50% of such subsequent financings for
12 months following the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Purchase Agreement, the Purchaser
agreed that it neither it nor any affiliate will execute any sales of any of the Company&#8217;s securities: (i) with respect to all such
sales (other than Short Sales (as such term is defined in the Purchase Agreement)), during the period commencing on the date of the Purchase
Agreement and ending at December 31, 2025, and (ii) with respect to Short Sales) only, during the period commencing on the date of the
Purchase Agreement and ending at December 31, 2025; provided that the foregoing restrictions shall not apply to any sales of any of the
Company&#8217;s securities at a sale price per share of common stock greater than $1.00.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Terms of the Pre-Funded Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Pre-Funded Warrants will be immediately exercisable
at an exercise price of $0.001 per share and will remain exercisable until such Pre-Funded Warrants are exercised in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price of the Pre-Funded Warrants,
and the number of Pre-Funded Warrant Shares, will be subject to adjustment in the event of any stock dividend or split, reverse stock
split, recapitalization, reorganization or similar transaction, as described in the Pre-Funded Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder will not have the right to exercise any
portion of the Pre-Funded Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, upon election
of the holder, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of such warrants. However, any holder may increase or decrease such percentage, provided
that any increase will not be effective until the 61st day after such election.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a Fundamental Transaction (as
such term is defined in the Pre-Funded Warrants), then the successor entity will succeed to, and be substituted for the Company, and may
exercise every right and power that the Company may exercise and will assume all of the Company&#8217;s obligations under the Pre-Funded
Warrants with the same effect as if such successor entity had been named in the Pre-Funded Warrant itself. If holders of the Common Stock
are given a choice as to the securities, cash or property to be received in a Fundamental Transaction, then the holder will be given the
same choice as to the consideration it receives upon any exercise of the Pre-Funded Warrant following such Fundamental Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Pre-Funded
Warrants or by virtue of such holder&#8217;s ownership of shares of Common Stock, the holder of a Pre-Funded Warrants will not have the
rights or privileges of a holder of Common Stock, including any voting rights, until the holder exercises such warrant.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Terms of the Common Warrants </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Common Warrants will be exercisable commencing
after the six month anniversary of their issue date (the &#8220;Initial Exercise Date&#8221;) and will expire on the fifth anniversary
of the Initial Exercise Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If at the time of exercise of the Common Warrants
a registration statement registering the issuance of the Common Warrant Shares under the Securities Act is not effective or available,
the holder may, in its sole discretion, elect to exercise the Common Warrants through a cashless exercise, in which case the holder would
receive upon such exercise the net number of shares of Common Stock determined according to the formula set forth in the Common Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price of the Common Warrants, and
the number of Common Warrant Shares, will be subject to adjustment in the event of any stock dividend or split, reverse stock split, recapitalization,
reorganization or similar transaction, as described in the Common Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder will not have the right to exercise any
portion of the Common Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, upon election
of the holder, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of such warrants. However, any holder may increase or decrease such percentage, provided
that any increase will not be effective until the 61st day after such election.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a Fundamental Transaction (as
such term is defined in the Common Warrants), then the successor entity will succeed to, and be substituted for the Company, and may exercise
every right and power that the Company may exercise and will assume all of the Company&#8217;s obligations under the Common Warrants with
the same effect as if such successor entity had been named in the Common Warrant itself. If holders of the Common Stock are given a choice
as to the securities, cash or property to be received in a Fundamental Transaction, then the holder will be given the same choice as to
the consideration it receives upon any exercise of the Common Warrant following such Fundamental Transaction. In addition, the successor
entity, at the request of holders of Common Warrants, will be obligated to purchase any unexercised portion of the Common Warrants in
accordance with the terms thereof. Notwithstanding the foregoing, in the event of a Fundamental Transaction, the holders of the Common
Warrants have the right to require the Company or a successor entity to redeem the Common Warrants for cash in the amount of the Black
Scholes Value (as defined in the Common Warrants) of the unexercised portion of the Common Warrants concurrently with or within thirty
(30) days following the consummation of a Fundamental Transaction. However, in the event of a Fundamental Transaction which is not in
the Company&#8217;s control, including a Fundamental Transaction not approved by the Company&#8217;s board of directors, the holders of
the Common Warrants will only be entitled to receive from the Company or its successor entity the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of the Common Warrant that is being offered and paid to
the holders of Common Stock in connection with the Fundamental Transaction, whether that consideration is in the form of cash, stock or
any combination of cash and stock, or whether the holders of Common Stock are given the choice to receive alternative forms of consideration
in connection with the Fundamental Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Common Warrants
or by virtue of such holder&#8217;s ownership of shares of Common Stock, the holder of a Common Warrants will not have the rights or privileges
of a holder of Common Stock, including any voting rights, until the holder exercises such warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summaries of the Offerings, including
the securities to be issued in connection therewith, the forms of Pre-Funded Warrants, Common Warrants, Placement Agent Warrants and Purchase
Agreement, do not purport to be complete and are qualified in their entirety by reference to the definitive transaction documents, copies
of which are attached hereto as Exhibits 4.1, 4.2, 4.3 and 10.1, respectively, and are each incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company notes that the representations, warranties
and covenants made by the Company in any agreement that is incorporated by reference herein were made solely for the benefit of the parties
to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements. In addition, the
assertions embodied in any representations, warranties and covenants contained in such agreements may be subject to qualifications with
respect to knowledge and materiality different from those applicable to security holders generally. Moreover, such representations, warranties
or covenants were accurate only as of the date when made, except where expressly stated otherwise. Accordingly, such representations,
warranties and covenants should not be relied on as accurately representing the current state of the Company&#8217;s affairs at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An opinion of Flangas Law Group, Nevada counsel
to the Company, regarding the validity of the Shares and the Pre-Funded Warrant Shares being issued and sold in the Registered Direct
Offering, and of Blank Rome LLP, securities counsel to the Company, regarding certain legal matters, are filed as Exhibits 5.1 and Exhibit
5.2, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Current Report does not constitute an offer
to sell or the solicitation of an offer to buy, and these securities cannot be sold in any state or jurisdiction in which this offer,
solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction.
Any offer will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration
statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02. Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The disclosure regarding the Common Warrants,
the Common Warrant Shares, the Placement Agent Warrants and the Placement Agent Warrant Shares set forth under Item 1.01 of this Current
Report is incorporated by reference into this Item 3.02. Such disclosure includes, but is not limited to, the fact that the Common Warrants,
the Common Warrant Shares, the Placement Agent Warrants and the Placement Agent Warrant Shares are being issued in private placement transactions
and have not been registered under the Securities Act and are instead being offered pursuant to the exemption provided in Section 4(a)(2)
under the Securities Act and/or Rule 506(b) promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 20, 2025, the Company issued a press
release announcing the pricing of the Offerings described in Item 1.01 of this Current Report, a copy of which is filed hereto as Exhibit
99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following exhibits
are filed herewith:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 12%"><b>Exhibit No.</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 87%"><b>Description</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center">4.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="kartoon_ex0401.htm">Form of Pre-Funded Warrant</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">4.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="kartoon_ex0402.htm">Form of Common Warrant</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center">4.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="kartoon_ex0403.htm">Form of Placement Agent Warrant</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">5.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="kartoon_ex0501.htm">Opinion of Flangas Law Group</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center">5.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="kartoon_ex0502.htm">Opinion of Blank Rome LLP</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">10.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="kartoon_ex1001.htm">Form of Securities Purchase Agreement, dated as of October 20, 2025, by and between the Company and the purchaser listed on the signature pages thereto</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center">23.1</td>
    <td>&#160;</td>
    <td style="text-align: justify">Consent of Flangas Law Group (included in <a href="kartoon_ex0501.htm">Exhibit 5.1</a>)</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">23.2</td>
    <td>&#160;</td>
    <td style="text-align: justify">Consent of Blank Rome LLP (included in <a href="kartoon_ex0502.htm">Exhibit 5.2</a>)</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center">99.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="kartoon_ex9901.htm">Press release issued by Kartoon Studios, Inc., dated October 20, 2025</a> (pricing of the offering)</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><b>KARTOON STUDIOS, INC.</b></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 50%">Date: October 21, 2025</td>
    <td style="width: 6%">By: </td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 44%">/s/  Andy Heyward</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>Name:</td>
    <td>Andy Heyward</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>Title:</td>
    <td>Chief Executive Officer</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZS9sEXdilRUWsIqWI22BHCbaZMok/PZK3NLaIw8AwvPe9J8RErGllGmQ4LcoCKmy7RnuEEi/IaM8YHPlmm0G4JV6N86ytH94fmFNgMDCzWCkdhMH6MA7rDNJpImWippDKTM7hsBPRV8/JXkyN1hvdgLY1HJg6Nug192NCpV9kqe2HqiOyM2QzkHE6ym9QqVSwp4d+Et8cFEUuoskwkVgz3bvgWr482i8JywbbUOdG+r/RBwRNSok= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>kartoon_ex0401.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PREFUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>KARTOON
STUDIOS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 65%">Warrant Shares: _______</TD>
  <TD STYLE="width: 35%">Initial Exercise Date: October [_], 2025</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PREFUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Termination
Date</U>&rdquo;), to subscribe for and purchase from Kartoon Studios, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up
to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The
purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 1.</U></FONT>
<U>Definitions.</U>
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated October 20, 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 2.</U></FONT>
<U>Exercise.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. The Company
shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s) contained on any Notice
of Exercise nor the authority of the person so executing such Notice of Exercise. No ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant
Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than
the nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise
of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise
price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to
the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.45in">(A) =</TD>
  <TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common
Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">(B) =</TD>
  <TD STYLE="text-align: justify"> the Exercise
Price of this Warrant, as adjusted hereunder; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">(X) =</TD>
  <TD STYLE="text-align: justify"> the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;)
is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common
Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by the OTC Markets, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT>
Mechanics of Exercise.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in
such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of
the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each
case after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery to the Company
of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m.
(New York City time) on the Trading Day immediately prior to the Initial Exercise Date, which may be delivered at any time after the time
of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York
City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share
Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written
notice to the Company at any time prior to the delivery of such Warrant Shares (in which case any liquidated damages payable under Section
2(d)(i) shall no longer be payable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iv.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by incorrect
or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof. The obligation of the Company to pay compensation for Buy-In under this Section 2(d)(iv) is subject
to delivery by the Holder of the aggregate Exercise Price in accordance with the terms of Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this
Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the
Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT>
 <U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except to the extent the Holder relies on a number of outstanding shares of Common Stock that was provided by the Company. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owing to the Holder.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 3.</U></FONT>
<U>Certain Adjustments.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time while this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to all of the record holders of the shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to all of the holders of shares of Common Stock, by way of return
of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the
beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or
any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all
or substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase
offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares
of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of
(i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the
Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission pursuant to a filing with the
Commission or in a press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective
date hereinafter specified (unless such information is filed with the Commission in which case a notice shall not be required), a notice
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 4.</U></FONT>
<U>Transfer of Warrant.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 5.</U></FONT>
<U>Miscellaneous.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment (it being understood that this Warrant shall not in any
case prevent the Company from effecting any such amendment, reorganization, transfer, consolidation, merger, dissolution, issuance or
sale). Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of
this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other
provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company
shall be delivered in accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendment</U>. Other than Section 2(e) and this Section 5(l), which may not be modified, amended or waived, this Warrant may
be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this
Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 65%">&nbsp;</TD>
    <TD STYLE="width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>KARTOON STUDIOS, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: _________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Title:</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To:&nbsp;&nbsp;&nbsp;kartoon
studios, inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">Name:</TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Address:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Signature: <U> _____________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Address: <U> ______________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>kartoon_ex0402.htm
<DESCRIPTION>FORM OF COMMON WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>KARTOON
STUDIOS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 65%">Warrant Shares: _______</TD>
  <TD STYLE="width: 35%">Initial Exercise Date: [_______], 2026<SUP>1</SUP></TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>Issue Date: October [_], 2025<FONT STYLE="text-transform: uppercase"><B></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS COMMON STOCK PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [______________]<SUP>2</SUP>
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Kartoon Studios, Inc., a Nevada corporation
(the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 1. </U></FONT>
<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated October 20, 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>1</SUP> Insert the date that is the six
(6) month and one day anniversary of the Issue Date.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><SUP>2</SUP> Insert the date that is the five
(5) year anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 2.</U></FONT>
<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein), in each case following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
The Company shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s) contained on
any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.738</B>, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT> <U>Cashless Exercise</U>.
If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not
available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time
by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the
quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.45in">(A) =</TD>
  <TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common
Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">(B) =</TD>
  <TD STYLE="text-align: justify"> the Exercise
Price of this Warrant, as adjusted hereunder; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">(X) =</TD>
  <TD STYLE="text-align: justify"> the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;)
is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common
Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by the OTC Markets, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&nbsp;&nbsp;The
Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT>
 <U>Mechanics of Exercise</U>.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in
such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of
the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate or a book-entry
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each
case after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery to the Company
of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written
notice to the Company at any time prior to the delivery of such Warrant Shares (in which case any liquidated damages payable under Section
2(d)(i) shall no longer be payable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iv.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by incorrect
or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof. The obligation of the Company to pay compensation for Buy-In under this Section 2(d)(iv) is subject
to delivery by the Holder of the aggregate Exercise Price in accordance with the terms of Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this
Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the
Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
 <U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except to the extent the Holder relies on a number of outstanding shares of Common Stock that was provided by the Company. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owing to the Holder.</FONT></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 3.</U></FONT> <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time while this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to all of the record holders of the shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to all of the holders of shares of Common Stock, by way of return
of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the
beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or
any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all
or substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase
offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares
of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company's control,
including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental
Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes
Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility or (3) the
365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C)
the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental
Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(d) and (D) a remaining
option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available
funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation
of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not
the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant
and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of
shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company,
may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the
obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt,
the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient
authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the
Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the
Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission pursuant to a filieng with
the Commission or in a press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective
date hereinafter specified (unless such information is filed with the Commission in which case a notice shall not be required), a notice
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice and provided, further
that no notice shall be required if the information is disseminated in a press release or document filed with the SEC. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 4.</U></FONT> <U>Transfer of
Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d)
hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act
and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current
public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder
or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 5.</U></FONT> <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment (it being understood that this Warrant shall not in any
case prevent the Company from effecting any such amendment, reorganization, transfer, consolidation, merger, dissolution, issuance or
sale). Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of
this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact
that the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the
Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company
shall be delivered in accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendment</U>. Other than Section 2(e) and this Section 5(l), which may not be modified, amended or waived, this Warrant may
be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this
Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 45%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>KARTOON STUDIOS, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: __________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Title:</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To:&nbsp;&nbsp;&nbsp;&nbsp;
KARTOON STUDIOS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT><U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">Name:</TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Address:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><U>______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Signature:<U> _______________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Address:<U> _______________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>kartoon_ex0403.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE
WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>KARTOON
STUDIOS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 65%">Warrant Shares: _______</TD>
  <TD STYLE="width: 35%">Initial Exercise Date: [_______], 2026<SUP>1</SUP></TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>Issue Date: October [_], 2025<FONT STYLE="text-transform: uppercase"><B></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS PLACEMENT AGENT COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [______________]<SUP>2</SUP>
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Kartoon Studios, Inc., a Nevada corporation
(the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of October 18, 2025,
by and between the Company and Dawson James Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 1. </U></FONT>
<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated October 20, 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>1</SUP> Insert the date that is the six
(6) month and one day anniversary of the Issue Date.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><SUP>2</SUP> Insert the date that is the five
(5) year anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 2.</U></FONT>
<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein), in each case following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
The Company shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s) contained on
any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall
surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall
be <B>$0.8118</B>, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space: nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.45in">(A) =</TD>
  <TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common
Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">(B) =</TD>
  <TD STYLE="text-align: justify"> the Exercise
Price of this Warrant, as adjusted hereunder; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">(X) =</TD>
  <TD STYLE="text-align: justify"> the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;)
is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common
Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by the OTC Markets, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.&nbsp;&nbsp;The
Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT>
 <U>Mechanics of Exercise</U>.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in
such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of
the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate or a book-entry
certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares
to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each
case after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1)
Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery to the Company
of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written
notice to the Company at any time prior to the delivery of such Warrant Shares (in which case any liquidated damages payable under Section
2(d)(i) shall no longer be payable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iv.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by incorrect
or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof. The obligation of the Company to pay compensation for Buy-In under this Section 2(d)(iv) is subject
to delivery by the Holder of the aggregate Exercise Price in accordance with the terms of Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this
Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the
Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
 <U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except to the extent the Holder relies on a number of outstanding shares of Common Stock that was provided by the Company. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owing to the Holder.</FONT></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 3.</U></FONT> <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time while this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to all of the record holders of the shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare
or make any dividend or other distribution of its assets (or rights to acquire its assets) to all of the holders of shares of Common Stock,
by way of return of capital or otherwise, other than cash (including, without limitation, any distribution of stock or other securities,
property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar
transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, the Holder
shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder
had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on
exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution (<U>provided</U>, <U>however</U>, that to the extent that the Holder's right to participate
in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution
to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of the Company&rsquo;s
assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or
50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company's control,
including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of
consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility
or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day
annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental
Transaction, (C) the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the
Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section
3(d) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer
of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election
and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the
Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission pursuant to a filieng with
the Commission or in a press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective
date hereinafter specified (unless such information is filed with the Commission in which case a notice shall not be required), a notice
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice and provided, further
that no notice shall be required if the information is disseminated in a press release or document filed with the SEC. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 4.</U></FONT> <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d)
hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act
and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current
public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder
or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap"><U>Section 5.</U></FONT> <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment (it being understood that this Warrant shall not in any
case prevent the Company from effecting any such amendment, reorganization, transfer, consolidation, merger, dissolution, issuance or
sale). Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of
this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact
that the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the
Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered
to the Holder by the Company shall be delivered to the address for the Holder in the Warrant Register.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendment</U>. Other than Section 2(e) and this Section 5(l), which may not be modified, amended or waived, this Warrant may
be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this
Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 45%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>KARTOON STUDIOS, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: __________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Title:</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To:&nbsp;&nbsp;&nbsp;&nbsp;
KARTOON STUDIOS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ ] if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT>Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;
</FONT><U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under
the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">Name:</TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Address:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><U>______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Signature:<U> ______________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Address:<U> _______________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>kartoon_ex0501.htm
<DESCRIPTION>OPINION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">Writer's email: kps@fdlawlv.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">October 21, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Kartoon Studios, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">190 N. Canon Drive, 4<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beverly Hills, CA 90210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Re: Registered Direct Offering </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as special Nevada
counsel to Kartoon Studios, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the issuance of 3,000,000
shares (the &ldquo;<U>Shares</U>&rdquo;) of common stock of the Company, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;)
and (ii) pre-funded warrants (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;) to purchase up to 6,903,048 shares of Common Stock (the &ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo;). The Shares and Pre-Funded Warrants are being issued in a registered direct offering and are being registered
pursuant to a registration statement on Form S-3 (File No. 333-276259) (the &ldquo;<U>Registration Statement</U>&rdquo;) filed on December
22, 2023 by the Company with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act of
1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), which was declared effective by the Commission on January 5, 2024, a base
prospectus included in the Registration Statement at the time it originally became effective (the &ldquo;<U>Base Prospectus</U>&rdquo;),
and a prospectus supplement dated October 20, 2025 filed with the Commission on October 21, 2025 pursuant to Rule 424(b)(5) under the
Securities Act (together with the Base Prospectus, the &ldquo;<U>Prospectus</U>&rdquo;). The Shares and Pre-Funded Warrants are being
issued pursuant to a securities purchase agreement, dated October 20, 2025, by and between the Company and the purchaser named on the
signature page therein (the &ldquo;<U>Securities Purchase Agreement</U>&rdquo;). This opinion is being furnished in accordance with the
requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In rendering this opinion,
we have examined such matters of fact as we have deemed necessary in order to render the opinions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We render this opinion only
with respect to, and we express no opinion herein concerning the application or effect of the laws of any jurisdiction other than, the
existing laws of the state of Nevada. We express no opinion with respect to any other laws or with respect to the &ldquo;blue sky&rdquo;
securities laws of any state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our examination of documents
for purposes of this opinion, we have relied on the accuracy of representations to us by officers of the Company with respect to all signatures,
the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us
as reproduced or certified copies, and the authenticity of the originals of those latter documents. As to questions of fact material to
this opinion, we have, to the extent deemed appropriate, relied upon certain representations of certain officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">For purposes of the opinion expressed below, we have assumed that a
sufficient number of authorized but unissued shares of the Company&rsquo;s Common Stock will be available for issuance when the securities
are issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based
upon the foregoing and subject to the assumptions, exceptions, limitations and qualifications set forth herein, we are of the opinion
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">The Company is a corporation validly existing and in good standing under the laws of the state of Nevada.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The Shares, when sold and issued against payment therefor in accordance
with the terms of the Securities Purchase Agreement and as described in the Registration Statement and the Prospectus, will be validly
issued, fully paid and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">The&nbsp;Pre-Funded&nbsp;Warrants have been duly authorized and
executed by the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">The Pre-Funded Warrant Shares have been duly authorized for issuance and, when issued and delivered against
payment therefor pursuant to the Pre-Funded Warrants, the Pre-Funded Warrant Shares will be validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is given as of
the date hereof. We assume no obligation to update or supplement this opinion to reflect any facts or circumstances which may hereafter
come to our attention or any changes in laws which may hereafter occur. This opinion is strictly limited to the matters stated herein
and no other or more extensive opinion is intended, implied or to be inferred beyond the matters expressly stated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing
of this opinion with the Commission and the use of our name in the section entitled &ldquo;Legal Matters&rdquo; in the Prospectus.&nbsp;
In giving this consent, we do not thereby concede that we come within the categories of persons whose consent is required by the Securities
Act or the General Rules and Regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><B>/s/ FLANGAS LAW GROUP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"><B>FLANGAS LAW GROUP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>6
<FILENAME>kartoon_ex0502.htm
<DESCRIPTION>OPINION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="image_002.jpg" ALT="" STYLE="height: 18px; width: 145px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1271 Avenue of the Americas | New York, NY 10020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">blankrome.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">October 21, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Kartoon Studios, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">190 N. Canon Drive, 4<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beverly Hills, CA 90210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as securities counsel to Kartoon
Studios, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the issuance of 3,000,000 shares (the &ldquo;<U>Shares</U>&rdquo;)
of common stock of the Company, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;) and (ii) pre-funded warrants (the &ldquo;<U>Pre-Funded
Warrants</U>&rdquo;) to purchase up to 6,903,048 shares of Common Stock (the &ldquo;<U>Pre-Funded Warrant Shares</U>&rdquo;). The Shares
and Pre-Funded Warrants are being issued in a registered direct offering and are being registered pursuant to a registration statement
on Form S-3 (File No. 333-276259) (the &ldquo;<U>Registration Statement</U>&rdquo;) filed on December 22, 2023 by the Company with the
Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), which was declared effective by the Commission on January 5, 2024, a base prospectus included in the Registration Statement
at the time it originally became effective (the &ldquo;<U>Base Prospectus</U>&rdquo;), and a prospectus supplement dated October 20, 2025
filed with the Commission on October 21, 2025 pursuant to Rule 424(b)(5) under the Securities Act (together with the Base Prospectus,
the &ldquo;<U>Prospectus</U>&rdquo;). The Shares and Pre-Funded Warrants are being issued pursuant to a securities purchase agreement,
dated October 20, 2025, by and between the Company and the purchaser named on the signature page therein (the &ldquo;<U>Securities Purchase
Agreement</U>&rdquo;). This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the
Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In rendering this opinion, we have examined: (a)
the Registration Statement, (b) the Prospectus (c) the Securities Purchase Agreement, (d) the Company&rsquo;s Articles of Incorporation,
as amended, (e) the Company&rsquo;s Bylaws, as amended; (f) resolutions adopted by the Board of Directors of the Company (the &ldquo;Board&rdquo;)
and the pricing committee of the Board, and (g) certificates of officers of the Company dated as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In such examination, we have assumed, without
inquiry, the legal capacity of all natural persons, the genuineness of all signatures on all documents examined by us, the authenticity
of all documents submitted to us as originals, the conformity to the original documents of all documents submitted to us as copies and
the authenticity of the originals of such latter documents. We have also assumed that the books and records of the Company are maintained
in accordance with proper corporate procedures. As to any facts material to our opinions, we have relied upon the aforesaid agreements,
instruments, certificates, documents and records noted above (including the representations, warranties, covenants and agreements of the
Company given in, pursuant to or in connection with the agreements, instruments, certificates, documents and records noted above). We
have also relied upon the opinion, dated as of the dated hereof of the Flangas Law Group, local Nevada counsel to the Company, that the&nbsp;Pre-Funded
Warrants were duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon the foregoing and subject to the assumptions,
limitations and qualifications stated herein, it is our opinion that the Pre-Funded Warrants when executed and delivered by the Company
will constitute the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with their terms,
subject to bankruptcy, insolvency or other similar laws affecting creditors&rsquo; rights and to general equitable principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We express no opinion herein as to matters involving
the laws of any jurisdiction other than the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is given as of the date hereof. We
assume no obligation to update or supplement this opinion to reflect any facts or circumstances which may hereafter come to our attention
or any changes in laws which may hereafter occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is strictly limited to the matters
stated herein and no other or more extensive opinion is intended, implied or to be inferred beyond the matters expressly stated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this opinion
with the Commission and the use of our name in the section entitled &ldquo;Legal Matters&rdquo; in the Prospectus.&nbsp; In giving this
consent, we do not thereby concede that we come within the categories of persons whose consent is required by the Securities Act or the
General Rules and Regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 62%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 38%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ BLANK ROME LLP</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>BLANK ROME LLP</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>kartoon_ex1001.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><B>SECURITIES
PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of October 20, 2025, between Kartoon Studios, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below)
as to the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares (each as defined below) and (ii) an exemption from the registration
requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D promulgated thereunder as to
the Common Warrants and Common Warrant Shares (each as defined below), the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE I.</B><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following
terms have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(mm).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Shares and the Warrants pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Shares and the Warrants, in each case, have been satisfied or waived, but in no event later than the second
(2<SUP>nd</SUP>) Trading Day following the date that NYSE American approval is received (or the third (3<SUP>rd</SUP>) Trading Day following
such date if such approval is after after 4:00 p.m. (New York City time) on a Trading Day).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrant delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) hereof, which Common Warrants shall be exercisable six (6) months and one (1) day following the date of issuance and have
a term equal to five (5) years from the initial exercise date, in the form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Nevada Counsel</U>&rdquo; means Flangas Law Group, with offices located at 3275 South Jones Blvd., Suite 105, Las Vegas, Nevada 89146.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Securities Counsel</U>&rdquo; means Blank Rome LLP, with offices located at 1271 Avenue of the Americas, New York, NY 10020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options not to exceed in the aggregate more than 5% of the shares
of common stock outstanding on the Closing Date to employees, consultants, officers or directors of the Company pursuant to any stock
or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the
members of a committee of non-employee directors established for such purpose for services rendered to the Company; provided, however,
that any securities issued to consultants under this clause (a) in excess of 200,000 shares are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith from the date hereof through December 31, 2025, (b) warrants to the Placement Agent in connection with the transactions pursuant
to this Agreement and any securities upon exercise of the warrants to the Placement Agent, if applicable, and/or securities upon the exercise
or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible
into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended
since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) any
3(a)(10) share made pursuant to (i) any court order in existence on the date of this Agreement; and (ii) any court order entered subsequent
to the date of this Agreement related to the exchange or settlement of up to $1.6 million of debt or liabilities; and (d) securities issued
pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that
such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require
or permit the filing of any registration statement in connection therewith from the date hereof through December 31, 2025, and provided
that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an
operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(mm).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $0.738, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and
other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date, provided that
the purchase price per Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Dawson James Securities Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the
form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the base prospectus filed for the Registration Statement, including all information, documents and exhibits filed with or incorporated
by reference into such base prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act, including all information,
documents and exhibits filed with or incorporated by reference into such prospectus supplement, that is filed with the Commission and
delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-3 (File No. 333-276259) filed with the Commission, including
all information, documents and exhibits filed with or incorporated by reference into such registration statement, which registers the
issuance and sale of the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants, and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Shares, the Pre-Funded Warrants (if applicable)
and the Common Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and
next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (excluding for the
avoidance of doubt, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid
as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, all exhibits and schedules thereto and hereto and any other documents or agreements
executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Pl, Woodmere,
NY 11598 and an email address of regina@vstocktransfer.com, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the
OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading
on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated
by OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell,
and the Purchasers, severally and not jointly, agree to purchase an aggregate of approximately $7.3 million of Shares and Common
Warrants; <U>provided</U>, <U>howeve</U>r, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser
(together with such Purchaser&rsquo;s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s
Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu
of purchasing Shares, such Purchaser may elect, by so indicating such election prior to their issuance, to purchase Pre-Funded Warrants
in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% (or, with respect to each Purchaser, at the election of such Purchaser at Closing, 9.99%)
of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Shares on the Closing Date.
In each case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser&rsquo;s Subscription
Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo;
(&ldquo;<U>DVP</U>&rdquo;) settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares
and a Common Warrant (and, if applicable, a Pre-Funded Warrant) as determined pursuant to Section 2.2(a), and the Company and each Purchaser
shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set
forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic transmission of the Closing documentation. Unless otherwise
directed by the Placement Agent, settlement of the Shares shall occur via DVP (i.e., on the Closing Date, the Company shall issue the
Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer Agent directly to the account(s) at the Placement
Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares
to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the
Company). Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company
and an applicable Purchaser, through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;),
such Purchaser sells to any Person all, or any portion, of the Shares to be issued hereunder to such Purchaser at the Closing (collectively,
the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions
by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, and the Company shall be deemed unconditionally
bound to sell, such Pre-Settlement Shares to such Purchaser at the Closing; provided, that the Company shall not be required to deliver
any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder;
and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant
by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person
and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects
to effect any such sale, if any. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Pre-Funded
Warrants) delivered on or prior to 4:00 p.m. (New York City time) on the Trading Day immediately prior to the Closing Date, which may
be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Pre-Funded Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date
(as defined in the Pre-Funded Warrants) for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>this Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a legal opinion of Company Nevada Counsel, directed to the Placement Agent and the Purchasers, in form and substance reasonably
acceptable to the Placement Agent and Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a legal opinion of Company Securities Counsel, directed to the Placement Agent and the Purchasers, in form and substance reasonably
acceptable to the Placement Agent and Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by
the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>subject to Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver
on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares equal
to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price (minus the number of shares of Common Stock issuable
upon exercise of such Purchaser&rsquo;s Pre-Funded Warrants, if applicable), registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vi)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of
such Purchaser&rsquo;s Shares and Pre-Funded Warrant Shares, if applicable, with an exercise price equal to $0.738 per share, subject to adjustment
therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(vii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>if applicable, for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of
such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount
applicable to Pre-Funded Warrants divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001, subject
to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(viii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ix)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a supplemental listing application (&ldquo;<U>SLAP</U>&rdquo;) in connection with the issuance and sale of the Securities has been
submitted by the Company to the NYSE American and the NYSE American has provided written approval of such SLAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>this Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>such Purchaser&rsquo;s Subscription Amount (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded
Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash), which shall be made available for
DVP settlement with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT>The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein
(unless such representation or warranty is as of a specific date therein in which case they shall be accurate in all material respects
(or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such
date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have
been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless such representation or warranty is as of a specific date therein in which case they shall be accurate in all material respects
(or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such
date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed in all material respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE III.</B><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules
shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each
Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all
of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free
of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to
the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not
have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms
hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with
its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and
thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or
articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an
event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as would
not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) the notice
and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares and
the Warrant Shares for trading thereon in the time and manner required thereby, (iv) the filing of Form D with the Commission, and (v)
such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Issuance of the Securities; Registration</U>. The Shares and the Warrants are duly authorized and, when issued and paid for
in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Warrants, when paid for and issued in accordance with this Agreement, will constitute valid and
binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general
principles of equity. The Warrant Shares are duly authorized and when issued in accordance with the terms of the Warrants, will be validly
issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized
capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared
and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on&nbsp;January
5, 2024, including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement.
The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration
Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose
have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and
regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule 424(b). At the time the Registration
Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement
and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and
will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus
or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the
requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form
S-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate market value of securities being
sold pursuant to this offering and during the twelve (12) calendar months prior to this offering, as set forth in General Instruction
I.B.6 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which
<U>Schedule 3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the
Company as of the date hereof. Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most
recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s
stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans
and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic
report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right
to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities
and as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or
giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of
Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate
the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are
no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange
or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares
was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two (2) years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has
received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As
of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements
included within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development
that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or
made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company equity compensation plans. The Company does not have pending before the Commission any request for
confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule
3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur
or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or
financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation
is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is
made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;), in each case that (i) adversely affects or challenges the legality,
validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision,
have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer
thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws
or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or threatened, any
investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has
not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the
Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that
their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and
foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Environmental Laws</U>.&#9;The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign
laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the
SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect
(&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to
the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material
respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of
this Agreement except where such expiration, termination or abandonment would not reasonably be expected to have a Material Adverse Effect.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it from having valid license
rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any
rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(q)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged,
including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither
the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant
increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(r)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transactions With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors
of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(s)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof and as of the Closing Date, and any
and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the
Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance
that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access
to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time
periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness
of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently
filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most
recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure
controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in
the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have
materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its
Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(t)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Certain Fees</U>. Except for compensation payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees
or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement
agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers
shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type
contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(u)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Registration Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the
Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(w)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the
Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements
of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the
Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(y)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their
agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not
otherwise disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing
representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company
to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including
the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were
made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken
as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The
Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(z)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any
offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the
Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration
of the Common Warrants or the Common Warrant Shares under the Securities Act, or (ii) any applicable shareholder approval provisions of
any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aa)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the
receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets
exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on
its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking
into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or
circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws
of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes
of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $100,000
(other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $100,000 due under leases
required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bb)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, subject
to permanent extensions (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment
of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any
Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(cc)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(dd)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Accountants</U>. The Company&rsquo;s independent registered public accounting firm is set forth on <U>Schedule 3.1(dd)</U> of
the Disclosure Schedules. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm
as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s
Annual Report for the fiscal year ending December 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ee)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> <U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the
Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions
contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ff)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity.</U> Anything in this Agreement
or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by
the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing
or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company
or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically
including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser,
and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or indirectly, presently
may have a &ldquo;short&rdquo; position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with
or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction.  The Company further understands
and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities
are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities
are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders' equity interests in
the Company at and after the time that the hedging activities are being conducted.&nbsp; The Company acknowledges that such aforementioned
hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(gg)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Regulation M Compliance</U>.&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases
of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with
the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hh)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>RESERVED.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i)
in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market
value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted
under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no
Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with,
the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results
or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jj)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Cybersecurity</U>.&nbsp; (i)(x) To the knowledge of the Company, there has been no security breach or other compromise of or
relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software,
data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf
of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have
not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach
or other compromise to its IT Systems and Data that would require notification to any third party under applicable law; (ii) the Company
and the Subsidiaries are presently in compliance in all material respects with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access,
misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the
Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards designed to maintain and protect its material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company
and the Subsidiaries have implemented backup and disaster recovery procedure consistent with commercially reasonable industry standards
and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kk)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ll)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(mm)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to
the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nn)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering
Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary,
threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(oo)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
no registration under the Securities Act is required for the offer and sale of the Common Warrants or the Common Warrant Shares by the
Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and
regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(pp)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the
Common Warrants or the Common Warrant Shares by any form of general solicitation or general advertising. The Company has offered the Common
Warrants and the Common Warrant Shares for sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo; within the
meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(qq)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Disqualification Events</U>. With respect to the Common Warrants and the Common Warrant Shares to be offered and sold hereunder
in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under
the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(rr)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered
Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale
of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ss)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the
Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of
time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which
it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will
constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)
as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business. Such Purchaser understands that the Common Warrants and the Common Warrant Shares are &ldquo;restricted
securities&rdquo; and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities
as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof
in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities
in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable
state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right to sell such Securities pursuant to a
registration statement or otherwise in compliance with applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 46.5pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on
each date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo;
as defined in Rule 144A(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 46.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that
such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth
the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the
foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions
of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio
managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to
the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.
Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions from and after December 31, 2025 (or
prior to such date, to the extent that such Short Sales or similar transactions of sales of any of the Company&rsquo;s securities are
effected at a sale price per share of Common Stock greater than $1.00).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>General Solicitation</U>. Such Purchaser is not purchasing the Common Warrants and the Common Warrant Shares as a result of
any advertisement, article, notice or other communication regarding the Common Warrants and the Common Warrant Shares published in any
newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser,
any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Removal of Legends.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Common Warrants and the Common Warrant Shares may only be disposed of in compliance with state and federal securities laws.
In connection with any transfer of Common Warrants or the Common Warrant Shares other than pursuant to an effective registration statement
or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company
may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable
to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Common Warrant under the Securities Act. As a condition of transfer, any such transferee
shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Common Warrants
or the Common Warrant Shares in the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES
INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Common Warrants or the Common Warrant Shares to a financial institution that is an &ldquo;accredited
investor&rdquo; as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser
may transfer pledged or secured Common Warrants or Common Warrant Shares to the pledgees or secured parties. Such a pledge or transfer
would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be
required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the
Company will execute and deliver such reasonable documentation as a pledgee or secured party of the Common Warrants and the Common Warrant
Shares may reasonably request in connection with a pledge or transfer of the Common Warrants or the Common Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Certificates evidencing the Common Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b)
hereof): (i) while a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following
any sale of such Common Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Common Warrants), or (iii) if such Common
Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants), or (iv) if such legend is not
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff
of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly if required
by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion
of a Common Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Common Warrant
Shares, or if such Common Warrant Shares may be sold under Rule 144 (assuming cashless exercise of the Common Warrants) or if such legend
is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Commission) then such Common Warrant Shares shall be issued free of all legends. The Company agrees that following
such time as such legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing Common Warrant Shares, as applicable, issued with a restrictive legend
(such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing
such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Common Warrant Shares subject to legend removal
hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with
the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means
the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the
Common Stock as in effect on the date of delivery of a certificate representing Common Warrant Shares issued with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Common Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend
Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to
be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Common Warrant Shares so delivered to the Company
by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases
(in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any
portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number
of shares of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<FONT STYLE="font-weight: normal"><U>Buy-In
Price</U></FONT>&rdquo;) over the product of (A) such number of Common Warrant Shares that the Company was required to deliver to such
Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the
period commencing on the date of the delivery by such Purchaser to the Company of the applicable Common Warrant Shares (as the case may
be) and ending on the date of such delivery and payment under this Section 4.1(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares shall be issued free of legends. If all or any portion of
a Pre-Funded Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Pre-Funded
Warrant Shares or if the Pre-Funded Warrant is exercised via cashless exercise, the Pre-Funded Warrant Shares issued pursuant to any such
exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration
statement registering the sale or resale of the Pre-Funded Warrant Shares) is not effective or is not otherwise available for the sale
or resale of the Pre-Funded Warrant Shares, the Company shall immediately notify the holders of the Pre-Funded Warrants in writing that
such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is
effective again and available for the sale or resale of the Pre-Funded Warrant Shares (it being understood and agreed that the foregoing
shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Pre-Funded Warrant Shares in compliance with
applicable federal and state securities laws). The Company shall use best efforts to keep a registration statement (including the Registration
Statement) registering the issuance or resale of the Pre-Funded Warrant Shares effective during the term of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Furnishing of Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Until the earlier of the time that (i) no Purchaser owns Securities and (ii) the Common Warrants have expired, the Company covenants
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act except in the case of a sale of all or substantially all of the assets of the Company, a merger or reorganization
of the Company with one or more entities in which the Company is not the surviving entity or any transaction or series of related transactions
as a result of which any Person (together with its Affiliates) acquires then outstanding securities of the Company representing more than
fifty percent (50%) of the voting control of the Company, unless the Company is the surviving entity of any such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all
of the Common Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with
Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy
the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes
an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information
Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash,
as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Common Warrant
Shares, an amount in cash equal to two percent (2.0%) of the aggregate Exercise Price of such Purchaser&rsquo;s Common Warrants on the
day of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (pro-rated for periods totaling less than thirty days)
thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is
no longer required&nbsp; for the Purchasers to transfer the Common Warrant Shares pursuant to Rule 144; provided, however, that in no
event will the aggregate amount of liquidated damages paid by the Company exceed six percent (6%) of such Purchaser&rsquo;s Subscription
Amount.&nbsp; The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;<U>Public
Information Failure Payments</U>.&rdquo;&nbsp; Public Information Failure Payments shall be paid on the earlier of (i) the last day of
the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day
after the event or failure giving rise to the Public Information Failure Payments is cured.&nbsp; In the event the Company fails to make
Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5%
per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages
for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner
that would require the registration under the Securities Act of the sale of the Common Warrants or the Common Warrant Shares or that would
be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would
require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing
of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the
material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents
as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release,
the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of
the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents,
including, without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In
addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar
obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers,
directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers
with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other
Person, that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison
pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted
by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the
Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company
reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing
to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To
the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates
delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and
agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any
of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the
Placement Agent, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject
to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Use of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from
the sale of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion
of the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b) for the redemption of any Common Stock or Common Stock Equivalents, or (c) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur
as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in
this Agreement or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity, or any
of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such
Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any
conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct) or
(c) ) in connection with any registration statement of the Company providing for the resale by the Purchasers of the Common Warrant Shares
issued and issuable upon exercise of the Common Warrants, the Company will indemnify each Purchaser Party, to the fullest extent permitted
by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material
fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in
any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated
therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in the light of the circumstances
under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are
based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for
use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities
law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser Party in respect
of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and, the
Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party.
Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the
fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof
has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such
defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel a material conflict on any material
issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for
the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under
this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not
be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity
agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or
others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and
keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the
Company to issue the Shares pursuant to this Agreement and the Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Listing of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and the Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and the Warrant Shares
on such Trading Market, except in the case of a sale of all or substantially all of the assets of the Company, a merger or reorganization
of the Company with one or more entities in which the Company is not the surviving entity or any transaction or series of related transactions
as a result of which any Person (together with its Affiliates) acquires then outstanding securities of the Company representing more than
fifty percent (50%) of the voting control of the Company, unless the Company is the surviving entity of any such transactions. The Company
further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application
all of the Shares and the Warrant Shares, and will take such other action as is necessary to cause all of the Shares and the Warrant Shares
to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary
to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to use commercially reasonable efforts
to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing
corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing
corporation in connection with such electronic transfer except in the case of a sale of all or substantially all of the assets of the
Company, a merger or reorganization of the Company with one or more entities in which the Company is not the surviving entity or any transaction
or series of related transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities
of the Company representing more than fifty percent (50%) of the voting control of the Company, unless the company is the surviving entity
of any such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Participation in Future Financing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) From the date hereof until
the date that is the twelfth month anniversary of the Closing Date, upon any issuance by the Company or any of its Subsidiaries of Common
Stock, Common Stock Equivalents for cash consideration, Indebtedness or a combination of units thereof (a &ldquo;<U>Subsequent Financing</U>&rdquo;),
the Purchasers together shall have the right to participate in up to an amount of the Subsequent Financing equal to 50% of the Subsequent
Financing (the &ldquo;<U>Participation Maximum</U>&rdquo;) on the same terms, conditions and price provided for in the Subsequent Financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) At least five (5) Trading
Days prior to the closing of the Subsequent Financing, the Company shall deliver to each Purchaser a written notice of its intention to
effect a Subsequent Financing (&ldquo;<U>Pre-Notice</U>&rdquo;), which Pre-Notice shall ask such Purchaser if it wants to review the details
of such financing (such additional notice, a &ldquo;<U>Subsequent Financing Notice</U>&rdquo;). Upon the request of a Purchaser, and only
upon a request by such Purchaser, for a Subsequent Financing Notice, the Company shall promptly, but no later than one (1) Trading Day
after such request, deliver a Subsequent Financing Notice to such Purchaser. The Subsequent Financing Notice shall describe in reasonable
detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised thereunder and the Person or Persons
through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet or similar document relating
thereto as an attachment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Any Purchaser desiring
to participate in such Subsequent Financing must provide written notice to the Company by not later than 5:30 p.m. (New York City time)
on the fifth (5th) Trading Day after all of the Purchasers have received the Pre-Notice that such Purchaser is willing to participate
in the Subsequent Financing, the amount of such Purchaser&rsquo;s participation, and representing and warranting that such Purchaser has
such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing Notice. If the Company receives
no such notice from a Purchaser as of such fifth (5th) Trading Day, such Purchaser shall be deemed to have notified the Company that it
does not elect to participate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) If by 5:30 p.m. (New York
City time) on the fifth (5th) Trading Day after all of the Purchasers have received the Pre-Notice, notifications by the Purchasers of
their willingness to participate in the Subsequent Financing (or to cause their designees to participate) is, in the aggregate, less than
the total amount of the Subsequent Financing, then the Company may effect the remaining portion of such Subsequent Financing on the terms
and with the Persons set forth in the Subsequent Financing Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) If by 5:30 p.m. (New York
City time) on the fifth (5th) Trading Day after all of the Purchasers have received the Pre-Notice, the Company receives responses to
a Subsequent Financing Notice from Purchasers seeking to purchase more than the aggregate amount of the Participation Maximum, each such
Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of the Participation Maximum. Pro Rata Portion&rdquo;
means the ratio of (x) the Subscription Amount of Securities purchased on the Closing Date by a Purchaser participating under this Section
4.11 and (y) the sum of the aggregate Subscription Amounts of Securities purchased on the Closing Date by all Purchasers participating
under this Section 4.11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) The Company must provide
the Purchasers with a second Subsequent Financing Notice, and the Purchasers will again have the right of participation set forth above
in this Section 4.11, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated for any reason
on the terms set forth in such Subsequent Financing Notice within thirty (30) Trading Days after the date of the initial Subsequent Financing
Notice.&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) The Company and each Purchaser
agree that if any Purchaser elects to participate in the Subsequent Financing, the transaction documents related to the Subsequent Financing
shall not include any term or provision whereby such Purchaser shall be required to agree to any restrictions on trading as to any of
the Securities purchased hereunder or be required to consent to any amendment to or termination of, or grant any waiver, release or the
like under or in connection with, this Agreement, without the prior written consent of such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) Notwithstanding anything
to the contrary in this Section 4.11 and unless otherwise agreed to by such Purchaser, the Company shall either confirm in writing to
such Purchaser that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its intention
to issue the securities in the Subsequent Financing, in either case in such a manner such that such Purchaser will not be in possession
of any material, non-public information, by the tenth (10th) Business Day following delivery of the Subsequent Financing Notice. If by
such tenth (10th) Business Day, no public disclosure regarding a transaction with respect to the Subsequent Financing has been made, and
no notice regarding the abandonment of such transaction has been received by such Purchaser, such transaction shall be deemed to have
been abandoned and such Purchaser shall not be deemed to be in possession of any material, non-public information with respect to the
Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) Notwithstanding the foregoing,
this Section 4.11 shall not apply in respect of an Exempt Issuance. Notwithstanding the foregoing, the notice time periods set forth in
Section 4.11 shall not apply in respect of an overnight or intraday Subsequent Financing and instead the Company shall only be obligated
to provide such notice to the Purchasers as it determines is reasonably practicable and following receipt of such notice the Purchasers
shall thereupon have a period of twelve (12) hours to indicate their interest with respect to an overnight Subsequent Financing and five
(5) hours to indicate their interest with respect to an intraday Subsequent Financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Subsequent Equity Sales.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From the date hereof until January 31, 2026, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to
issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration
statement or any amendment or supplement thereto, other than the Prospectus Supplement, the filing of any registration statement or any
amendment thereto with respect to the Common Warrant Shares, the filing of a registration statement to register new warrants issued as
part of a warrant inducement, the filing of a registration statement or any amendment or supplement thereto for an &ldquo;at the market&rdquo;
offering, the filing of any amendment or supplement to an existing registration statement, or filing a registration statement on Form
S-8 in connection with any employee benefit plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From the date hereof until the two year anniversary hereof, the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the
Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right
to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is
based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance
of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future
date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price regardless
of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled,
<U>provided</U>,&nbsp;<U>however</U>, that, following the one year anniversary hereof, the entry into and/or issuance of shares of Common
Stock in an &ldquo;at the market&rdquo; offering shall not be deemed a Variable Rate Transaction. Any Purchaser shall be entitled to obtain
injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate
Transaction shall be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Equal Treatment of Purchasers</U>. No consideration (including any modification of this Agreement) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also
offered to all of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting
of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants
that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any sales of any of the Company&rsquo;s
securities: (i) with respect to all such sales (other than Short Sales), during the period commencing with the execution of this Agreement
and ending at December 31, 2025, and (ii) with respect to Short Sales only, during the period commencing with the execution of this Agreement
and ending at December 31, 2025; provided that the foregoing restrictions shall not apply to any sales of any of the Company&rsquo;s securities
at a sale price per share of Common Stock greater than $1.00.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers,
covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the
initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this
transaction and the information included in the Disclosure Schedules (other than as disclosed to its legal and other representatives).&nbsp;
Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time described above in the first sentence of this Section 4.14, (ii) no Purchaser shall be
restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws
from and after the time described above in the first sentence of this Section 4.14, and (iii) no Purchaser shall have any duty of confidentiality
or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors,
employees, Affiliates or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release as
described in Section 4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set
forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Capital Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward
stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest
of the Shares, other than a reverse stock split that is required, in the good faith determination of the Board of Directors, to maintain
the listing of the Common Stock on the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver the Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Form D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Common Warrants and the Common
Warrant Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall
take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Common
Warrants and the Common Warrant Shares for, sale to the Purchasers at the Closing under applicable securities or &ldquo;Blue Sky&rdquo;
laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Registration Statement</U>. As soon as practicable (and in any event within thirty (30) calendar days of the date of this Agreement),
the Company shall file a registration statement on Form S-1 (or other appropriate form if the Company is not then S-1 eligible) providing
for the resale by the Purchasers of the Common Warrant Shares issued and issuable upon exercise of the Common Warrants.&nbsp; The Company
shall use commercially reasonable efforts to cause such registration statement to become effective within ninety (90) days following the
Closing Date and to keep such registration statement effective at all times until no Purchaser owns any Common Warrants or Common Warrant
Shares issuable upon exercise thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Termination</U>.&nbsp; This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder
only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other
parties, if the Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>,
<U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise
notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the
Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication
is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to
be given provided, further that no notice shall be required if the information is disseminated in a press release or document filed with
the SEC. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that
any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written
instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares
and the Pre-Funded Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser)
or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment,
modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of at least 50.1% in
interest of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with
respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver
of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any
party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the
other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties
of the Company in Section 3.1, the covenants of the Company in Article 4 and the representations and warranties of the Purchasers in Section
3.2. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not
for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this
Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or
with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations
of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for
its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such
Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
(including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method, such signature shall be deemed
to have been duly and validly delivered and shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right); provided, however, that in the case of a recission of an exercise
of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including issuance of a replacement
warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in
the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the
defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law
(including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction
Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in
any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers
as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any
way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this
Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through the legal counsel of the Placement Agent. The legal counsel of the Placement Agent does not represent
any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and
Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.
It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between
the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the
Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and
other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.19</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Saturdays, Sundays, Holidays, etc.</U>&#9;If the last or appointed day for the taking of any action or the expiration of any
right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next
succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.20</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.21</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER
PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 62%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>KARTOON STUDIOS, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="width: 38%; font-size: 10pt; layout-grid-mode: line"><U>Address for Notice:</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: __________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Title:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E-Mail:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">TOON</FONT>
SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: _________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Warrants to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pre-Funded Warrant Shares: __________________
Beneficial Ownership Blocker <FONT STYLE="font-family: Wingdings">o</FONT> 4.99% or <FONT STYLE="font-family: Wingdings">o</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Common Warrant Shares: __________________ Beneficial
Ownership Blocker <FONT STYLE="font-family: Wingdings">o</FONT> 4.99% or <FONT STYLE="font-family: Wingdings">o</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">o</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company
to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing
shall occur by the second (2nd) Trading Day following the date that NYSE American approval is received (or the third (3rd) Trading Day
following such date if such approval is after after 4:00 p.m. (New York City time) on a Trading Day)and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>kartoon_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-size: 12pt"><B>Capital
infusion fuels the global launch of Winnie &amp; Friends, the Stan Lee Universe expansion, and the Bitcoin Brigade rollout Investment
validates Kartoon Studios&rsquo; strategic direction</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">BEVERLY HILLS, Calif., Oct. 20, 2025 (GLOBE
NEWSWIRE) -- Kartoon Studios, Inc. (NYSE American: TOON) (the &ldquo;Company&rdquo;), a leading global producer and distributor of premium
children&rsquo;s and family entertainment, today announced it has entered into a securities purchase agreement with a single institutional
investor for the purchase and sale of approximately $7.3 million of equity in the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The closing of the Offering is expected to
occur on or about October 22, 2025, subject to the satisfaction of customary closing conditions, including approval by NYSE American.
The gross proceeds from the Offering are expected to be approximately $7.3 million before deducting placement agent fees and other offering
expenses and assuming that none of the common warrants are exercised. The potential additional gross proceeds to the Company from the
common warrants, if fully exercised on a cash basis, will be approximately $7.3 million. No assurance can be given that any of the common
warrants will be exercised. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes.
This capital infusion will fuel the global launch and marketing of the upcoming<I>&nbsp;Hundred Acre Wood&rsquo;s Winnie &amp; Friends</I>,&nbsp;<I>Stan
Lee Universe</I>&nbsp;expansion,&nbsp;<I>Bitcoin Brigade</I>&nbsp;rollout, and ongoing growth and content acquisition for Kartoon Channel!&rsquo;s
streaming service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The investor will purchase 3,000,000 shares
of common stock and pre-funded warrants to purchase up to 6,903,049 shares of common stock in a registered direct offering and common
warrants to purchase up to 9,903,049 shares of common stock in a concurrent private placement (together with the registered direct offering,
the &quot;Offering&quot;). The combined purchase price is $0.738 per each share of common stock and accompanying common warrant and $0.737&nbsp;per
each pre-funded warrant and accompanying common warrant. The common warrants issued pursuant to the concurrent private placement will
have an exercise price of $0.738 per share, will be exercisable after the six month anniversary of the date of issuance, and at any time
thereafter up to the fifth anniversary of the initial exercise date. The investor has agreed not to sell any Company securities until
December 31, 2025, at a sale price less than $1.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Dawson James Securities, Inc. is acting as
placement agent for the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The common stock, the pre-funded warrants
and the underlying shares will be issued in a registered direct offering pursuant to an effective shelf registration statement on Form
S-3 (File No. 333-276259) previously filed with the U.S. Securities and Exchange Commission (the &quot;SEC&quot;), under the Securities
Act of 1933, as amended (the &quot;Securities Act&quot;), and declared effective by the SEC on January 5, 2024. The common warrants will
be issued in a concurrent private placement. A prospectus supplement describing the terms of the proposed registered direct offering will
be filed with the SEC and once filed, will be available on the SEC's website located at&nbsp;http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The private placement of the common warrants
and the underlying shares will be made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act and/or
Regulation D thereunder. Accordingly, the securities issued in the concurrent private placement may not be offered or sold in the United
States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities
Act and such applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">This press release does not constitute an
offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About Kartoon Studios</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Kartoon Studios (NYSE AMERICAN: TOON) is a
global leader in children&rsquo;s and family entertainment, delivering premium content and high-value intellectual property to millions
of viewers worldwide. The company&rsquo;s portfolio features globally recognized brands including the Stan Lee IP, including Stan Lee&rsquo;s
Universe, Hundred Acre Wood&rsquo;s Winnie and Friends Rainbow Rangers, and more. Kartoon Studios operates Mainframe Studios&mdash;one
of North America&rsquo;s largest animation producers&mdash;with more than 22,000 minutes of award-winning programming delivered. Through
its Toon Media Networks division, including Kartoon Channel!, Kartoon Channel Worldwide in over 60 territories, Ameba, and Frederator
Network, Kartoon Studios reaches audiences across linear television, AVOD, SVOD, FAST channels, and top streaming platforms. Kartoon Channel!
is consistently rated the #1 kids&rsquo; streaming app on the Apple App Store.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>Certain statements in this press release
constitute &quot;forward-looking statements&quot; within the meaning of the federal securities laws. Words such as &quot;may,&quot; &quot;might,&quot;
&quot;will,&quot; &quot;should,&quot; &quot;believe,&quot; &quot;expect,&quot; &quot;anticipate,&quot; &quot;estimate,&quot; &quot;continue,&quot;
&quot;predict,&quot; &quot;forecast,&quot; &quot;project,&quot; &quot;plan,&quot; &quot;intend&quot; or similar expressions, or statements
regarding intent, belief, or current expectations, are forward-looking statements and include statements regarding: the completion of
the Offering, the expected timing for closing of the Offering, the exercise of the common warrants prior to their expiration, the receipt
of NYSE approval and the expected use of proceeds from the Offering. While the Company believes these forward-looking statements are reasonable,
undue reliance should not be placed on any such forward-looking statements, which are based on information available to the Company on
the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various
risks and uncertainties, including &nbsp;market conditions, the satisfaction of customary closing conditions related to the offering and
those other risk factors set forth in the &ldquo;Risk Factors&rdquo; section of the Company&rsquo;s Annual Report on Form 10-K for the
fiscal year ended December 31, 2024 and in the Company's subsequent filings with the Securities and Exchange Commission. Thus, actual
results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result
of new information, future events or otherwise, except as required by law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M 6T# 2(  A$! Q$!_\0
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M768GT=4BO_L2VZ*?.SY6%^7<.3ZD'VKF--_Y.NUC_KT7_P!)XJ]L1Q)&KJ&
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  2 ) # 2(  A$! Q$!_\0
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MX_,0QL/8J<?A3 ZCPWJ5RLL^A:J^[4K( B4_\O,)^[(/?L?0_6LV]GF%]XW
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BY1@<#T%8"65KYB_Z-#]X?\LQ117/->\>UAY/V6_?\V?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>toon-20251020.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa2CuaPty552OYkxvmR1fRnKTycv50yLaCMiM/VWYaYH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:TOON="http://gnusbrands.com/20251020" elementFormDefault="qualified" targetNamespace="http://gnusbrands.com/20251020">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://gnusbrands.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="toon-20251020_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="toon-20251020_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>toon-20251020_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>toon-20251020_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="toon-20251020.xsd#Cover" roleURI="http://gnusbrands.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://gnusbrands.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 20,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KARTOON
STUDIOS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001355848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-4118216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">190
N. Canon Drive, 4th Fl.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Beverly
Hills<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">273-4222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TOON<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="kartoon_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gnusbrands.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="kartoon_8k.htm">kartoon_8k.htm</File>
    <File>toon-20251020.xsd</File>
    <File>toon-20251020_lab.xml</File>
    <File>toon-20251020_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "kartoon_8k.htm": {
   "nsprefix": "TOON",
   "nsuri": "http://gnusbrands.com/20251020",
   "dts": {
    "inline": {
     "local": [
      "kartoon_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "toon-20251020.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "toon-20251020_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "toon-20251020_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://gnusbrands.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kartoon_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kartoon_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://gnusbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001683168-25-007700-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-007700-xbrl.zip
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M*'^+'=$95=P -;31U:KN"Q\7S:F1F5/@#(91>B%F^*\.QLUM=B#X9;DK0$W
M+,?$('?;X/E2L'36U!S07!M2@OCN/O#:KRECN0H? GP0&-#R$\]&CO:#+0PA
M\:0%^*'M2(Q8K5*M5=@!EA!C,M2W.--X/MM''\O!<A.V.P@$0425A9V]B(W4
M<QC";4?E_PGEV7<","",,#3*]7LVV_,]</T"1,7. N<*:&*=@?HA(H!'\ )H
M<.JQ['F;$OO( SQ[#F'RQ'9\Z+#M]2IL&>RIA642]>H;Y1[1WVIO5ACI'_+$
MP1!S%B8>,UAHL,#@%W#-/=014QV=Z<<Q<\5]*M^ X<4N3C1!/07\Z'A7(HS\
MP,KK)= OEU*@G41,L/V>#AYP-!N?.8B?XA_P<=Q/B2T[*QA7<!,(M"6+^)I%
M3(H4<U(RIT8)?$_\AZE;%\PUR(/7\>J5_V(0FJI3>A+ "#, AI4%,%)=FZA'
M,AMD\'$@ROT)N6I3'J!;%V(X(XD*SP[ELR_J63P[H%>\L9,Q_G6]U*K"^IHM
M2ZT-%F".F][UN:Y9>OER=LN.WH1>(HAC*8ALK 4QLU3=T%(2RV*)33I75$R6
M/$^L&Y<,7,D'P$(#=39/DJ"E2<"R)+#F29 >9F[YFOG%M0AZX!+CLGLT%NST
M1F.SPBZ@KUO4EV2@8A6&]4SDVJ#G?"7<&:,K) (E&9Z,8O?4Z^I (M;@ZQH:
MS2KI)C')($ P5JRG%E94@W^^]KPP5(JX'@,9Y8KCI2(=>ZX?(G!KQ8JVKA5M
M..G^C;NFU(^L-N(]75S4@W%@:F"5L0_<59 #VY%YF10SJ<=X@#(M0M S\(5
M\QUSK 7.0$A!5 ^48,CZ@3_*3!L&IRJJ:P>S\L 8_]JH-!B$2BZ,74(X6E?$
MP<KCCJ(ACX!N,]85>E0;9,/W5%"H6%FJ-BLC:#1=Z?@Q4 Q8$8554PFO#O#?
M?2%D2WFT*%;%2'TO1'O#9^3I=V>F_@3O!F%TDC*E^$@6W)E%(]@L(X]36"HN
M V(,F\&J. A_UW5ZR8AS DDCY&BVU'"L>#CK'L-M2/F76J.4,VJH_)<TB?6J
MR.B!!R_ @-"TG@JA^D5D45;TA28DX8DHS?&6R?$$2TS]X)*$C(^="*$'H.!
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M_@3"8Y8*ZG!*X ]="4FBY5I]Q:(K.D/C;#H.KU-,:@VI%!;>>IB8S51"VD6
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M]RQ,R/JXNS0)MB1,0%C>49H$.V&RF\-]1]N?[*+M#Q!M?[*+MO_>[J(=$9\
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MVC8<:(5%(P/UK=>42M!%Z,[ZE-O.WU;T;VQ:IU,=LHIK 1V1^)P:!BE' IY
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M<R/IP2\QO%]#=O0*@9'*G<$Y(_,4\K-=5K8082^='6CH2K[9P"DZ[A"J.M)
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M;H-=#%J;^+P#8=GJ=:^;W%N*J'!HQKKE0$\F"B:';'0+TH:+3*T;&$W5CS!
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MF-C ."2L%;FT5N&UE=KE^1W"-BU:<HKZI5CA ],BD0E6J699(58L_E;Z,;$
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M%,'$D#:Q<8P\EZ&$DI("^1QN"1=]$?=OCHZ0Q65S)) &R/!F,7$])( B G&
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MG2'M0RSRJ4U$V!<^6M2K:S5^LT3G0+G40,[DFR5_U-D(L9C+X&>\8DW;KS.
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M2*28<9>/41 N(=?OCJB^ ??)FK/%_M<Z1@.82YV<$FGW#JI8IF086;XZ+JC
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M>\<'?T<)^L/;\_?O7O]_4$L#!!0    ( %.*55MU:^3OMDD  #JW 0 2
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MY^_W_Q?&AQ>$-(8SB;/!_WM_=$;3.,=-:I@$'B.^F/8 3Z+;H=/>.SU]>W1
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M7J0SZ"UY=]$!5$>/CKYZ$IW#W7(5_1<<Q@IT].OY ?KRP9"%$3Z)H94J^ME
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M=V":VT<X(6>=!Y^ 0"YFJ?R>R!DC3#E>8VH0I7K ,S:PLK'.\'@XX$?=CN4
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MM$6RV+7H=^R*5GOW P*W/5H;8,SHY9#]&%L2 ?@7%>WIS#=$90ZNM$PR+L!
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MNL&K3$!5LUF)?DWL9XZIL>XU,KMP=\!*E)RAPS) T]/96X!Y4E9)A;$%JE3
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M/LPL WK$>L:,1NO:05_TO2 PE-O/F#OEM3J=ZNS%3)@3GN-V+I&?@ ZPBM"
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M>]7).>[':,DD!:C0G'?GCG31[/8J=&T^.=;.'I%0;?>I#S J-4)36W616B_
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M9JT%2O-:B(/LCZ#,3SN]%;8P3DUTG@A?<>\DZ'?&$6NS=*T0L(WVG< E+);
M#V)%C2%9L:.3"YM#OK$<0VE4Z#%*80J%C$:&#BW,>J%K[&7(-@\(,#!7:_/4
MDGT'$\1Q+W))@&5C78YI?K?!^["*BS:$B@97.>E'":N**#ANJ=8F[Z:=:E]+
M,7E)'%006>*$4*3BI,+Y/K#/1)BRYB@P5%6XG!AL"?ML[W_AZU,,M@QQ;2EV
M>L8V5B.ZRYP=1)V7NDJSE%!D2XM#] ;)DC):XH93P@3GCHM985>NX$>DW[$$
MI=1KQ!N4:;&NB"J[T@ERPB7M% =_.KEDNL+KJ-3%[A/4:E;EB0:0RP:T&<O"
M8QTIQ&,TM<AF?Z:&89,V0!D[> 5MP([1CYC=8"SY^*4![=:T^^0@F:IT2O6_
ML9(75W'AZBN>P-GI**PV^=./4^S'W;4<;A@.JGC .D6_L4+ML;<1Y0U*CK2@
M^&S'"]KPSB1"VYOM&X6H[:,F9"5@KV3M0,FZO-PY,YH4]8A^HJW$]#MD"W=L
M,L>.)!4C0I(HI.?,36\RO,"K,5_6"WD2HEK*\UYN<E-)LD91>DB(%>X5%X+P
M($>8@W2US@)3PMV#839).]][ >9IEA+LPT/&R404\+@Z#XIF4;SN( ;@CD^I
M3D#LC#7B2(\%BD'1-<4CN_ I+51K2GY3V;K+G6_C' [2>M(Y&ZFHXUE\JX0,
M;6+.+:^T;$;X8VM>.H:#X6";\N<PA[%W<[!Q.LL2P@Q+JHD /.(FAV[JF*T:
MC+D=]C8+4J\*[>D_?A\9='6U8QET<GYR]O/),1EO^R7<Q1+"T=MM(A"QK;WF
MTFAPDBWCU DJ$4'=M$O4Y-HV;#\14[OJV@U<0K:9$>92=,!72;,BCI@>VZ?=
MK(N="O&*Y46RET=WM5;*%&)C2U6U;AH=-BN*X.VDEP7O=[D4J(.E5 #/C9!G
MQI5I4AE[67)##*9=\ZO9;6\?NG+2S=X1?+J3%)&N>K@QP#23US@0FJM1;MD!
MI9")YW] K HG&*P$EX13V&@Q#CI729:E4%-Z;AK_JUG!6&JYKJD17("P&5S1
MF*\/8011&"4)M><Y6&G^9E& 1UW8J(O]!168)MS4I;\&]8U!:V&6]Y5PZ>RO
MK'T?[A4#?[*/@7^*&/B3?0S\<SN-.]#"?OUUQ\5+-E-,BF#C5IOPH"5AMED+
MJM9*-Y5"9.[Z]J:R=0B5+N=KB45 4[;V,%618+-T-Q;:;&UJ'RWDJ$+O*9X[
M,[O*BZRXW B#V7*U1H\95_=$\@E3WQ3ENPJAPN4<8:.@.Q2+FOXU'( 2DVCV
M4%&^$IN,J4*^,]@&Q9)2T50Y[ HI[E+Z])K3P5QTN;Y*R[F4Y*8V;=W,-J,<
M(5W3&O/,_KU.5Q9YK$8WLFECZ, /D@=A?_!@Z<7'\")=38_5U4V0M^T"LJV2
MD\,!N[5I46N.G=B$Y+XD5',MO?4Y^RJ_Y[:$G2C-X]#9PCN(U)_6%A)74L>8
MPW<R0T;( %ZT%D6880--^6DKRYU=YZWI2DKC(PT-0NTT#Y-*9!<)_5BC<BZS
MOY8$J5S;NO7XS*]KCFR2'P?=QK!?N\OLRDI@EB"M1%).4V0%8>!%D,%#/BKZ
M)7)&N\R1V-?:(P7<4JO:*NYHR:B4S? 4B^/L&OEF\$?:;]:U5.(4Y)]9[N'(
M\HIW_8("D>O<5GWE1/-8:LS"M,#F\ 59K7NOF+O5=_F;L(?OGW?6FT\FX2^6
MGG7 8M=;U#5="B6FD 4HH8 YQ&A*4G=4Y=DJ61A,/)U7@:O3E^%ES@&<2"Z1
M*;TE),F"L")-"\7VC^EJ: ,(SSJ&<XJ5*67>,*Z1H\'<7EK<HQV+]=0'SFX_
M1:TI0<MRO>+<+UC42BK8X!;>^.*:; ##E[FDD?9-':PPB.T2B[)#DSB%W!%K
M6^X-J]VH,._>[5:%>4VY;)2K(?DN$^8@D1+L]TEEPH]B*Y#DL?^MXA5\/\V%
M]SPF\BE,I(LCJ7YFU0$.U_N"2;=DP@1%!U3U(7SL[<'Y 9S[W%;VGB_3W(+^
MV24V'-PV![8'U-8%'HHUO/48RW]S#:.1UR)>OY@\#XKP[H_%+HY%ENWV6-!2
MGQD0]F]*%.(@J'\L,M)LGWLV^;[J8E[-,XA28"01;Y_2,,L7MWDE;6J&>F;Y
M8.>9*OQE^5"__N8K7P=,-(TS5!W7V(NYX2):7W^IBVBU*],P]*(J;,GF:+U"
M1W(+[X4:H*GJ_2[>R2Y>+G>[BY]AZ4B_;UVAM=N%NEAM31>K9R-4V?%6XG>]
MC0HC\99\$FS):(0_\7+SV8_/)RUSBRO(V<BR1#!< 8T?2!TO?![V"V81@.,
M6QC4(5:HZ$W#@7]5X[&P9/IOFY3B)A=*>:YDWHNMPOKOUP3#F=$%\N0?8P<=
MDM$$3#P,Q+'F298P^<AU43N>GM2FH]8WT.+F0=C^4<<+ZJ)&U580-$20;6N-
MDCD*6FS-6,FNQ8;UZE^CQA3?95K#$N.->;61(02MR=QFC#==9.P9)#@8X_!R
MT":LX>]LL+L/CR7O_<:W%X^[$(]YOEOQ^!/Q/;U,R'WAZ%_Q.G=V6YM0LXOK
MA KMT)6/10?PME><>\SMQL"^SI);WH.A8U<87GWPSIB5)4%C-@S\*R#!L_TC
M!5B,2ZO&7F@TZ)G[O1/)7U&I33#DG)K@^\)D6)F;G(9;Q3_8[4FI'<ECT^,6
MROWF&@P'+Y,;3=XU9N4E+PASSAZ)-\S)A[UB_Y^@? /?3<BW<HF3$VN&#R3^
MFCMS0GEZTORZR*Y= 8A^NZ,KHZ8YG@B'@P)F)5FYRD2Z%]M#?06J(]CI>^[6
M'4F;HMBMM'G#V'*/N_J]V*8Q<R)&AW1/P=0F1W*J<MYM>CGQ+K/C2G&ZWHL@
MV5K;*HNBD761="8=L41VE:N:?>CBE0V+KI0@E7.A>;:R"OVN@=M7X+:Z$./^
MF.WBF*U6.V=V_P&6&[6S<X9<*E-]FQK:8E7OYLZY2H2]G"FU$8&JHF^NR.B=
MSX10S2RQ@4OI>*4Z3E>9?)[,*8!?N:([79WR;QL.7"^4_=_1#<*GTIG*L\Z#
MB0$,YO*14))<X""OX)4I<\)@2>\")56S?OEPH/P89\CV\>3A8:_\V9^[?1_N
M@]#Y<H_0^10(G2_W")W/[33N0!OX][]WK@T<IQ7BASV X01Q%H*7_J7#A&O>
MX-OO3F9MLI<O::>H$CA=E-#2I1%  _Q>+L OMU0,T5G)#BND/)!@ LRI]%Q1
M5G&0*HD7,6;YEHU8&WK09FLTP574C:]R^;.IYS"O/[+1N\1NX\NVJ!(.^/ 4
M%!2FT^-JL=C8T<-_-#V.+2XK[>,49Z:X(RN5? /B$ L,U+[8!1-I>@_HJKC!
MKEA5#E$N!0:\1XE-<33,/S:';N9,KD7K\/CADTB6J;T08YL08VO0Z/F1K%+'
M,I(XUGH:+JE3(P3@X QIF!$M#S1S31N&M4[M[X -4S6CF#)_TLJS9([=*TJK
M:LT;6YS@#;,RG:J1PHX;S<>CPS'EA!71Z)KRF7JMP%&B?>;=ARATTZBD_:3G
MU$4S&38HOKI71^2<QG\]:C/V8ZD/=O_.-2)AAEXW2K&77%-';(Z_ZYSFAA^[
MKY=MW9J==F8>NQ*E1/U;*S\8I]QRX0'/6Z?9V7FJW;#-V,/!?(74#N4;WKYR
MC+2^;9@75^S6>]OVVO-.[JFRW#$,@S9NN%OEBGKM<OZZTO9")FX;?KY)2@<K
M%%Y07:^@?4"& W[GF,6E0Z1BX0:IIT.Y@Z/N>-88#N9RG8O37.<[NJ30E6)L
MZF;V09'I"E_LDPQWO*.K:M>:5RV@FJT*F):TM-,(:[KI\D#T)*W>E)15&[O<
M)?'#J)HHMB <OJ3G8FJ"J;OO#Y>RYO&Z'BX;JZ)!254EY->'"P/F+-X"WYT:
MIK+_33W[:QV23WLT'AT<[9@"H.W"_\6[\%NN?Y79J;AS%IP%9[(%-;"@:BZB
MTJO'A+C+TY(Q;//&&3?=E8"X4%A'@;@&O ^?6A195MQ4T6B=9U)VC*+MEMV'
M6ZY5 6QBI1D.*'6]QF)0#$>:V@ (,F)4#L>,/Q]_^RDVURYD_]$A^B=N[\*3
M0_)9[*)(X8Y5&57,ZFDTL0%7WL7G+18B\<@GN0*1<P#40C3F:^;JL[SJ<RDI
MM<2(]35,XAR^M_0PO+UACUTB$Y@S+KV9PUD"O+&#TA]B6_L7B?/=8[U)O"-G
M.[NN8D_U'I.Y#/I/=96N8B;=0:7*EIIB/@@)[5IJ1C):^:BYJ'1(_R?X$\1H
MKY=+FW/;S](GZ)1.VAB>&)_2Z\L&KAGLKDT5'TESZ<9L7=!]+;X$N0^%'6@[
M:0U#ZTU)DTG8AVF+DNI6$L)MPU/8"]HO*L-AR@7R<O*8<!$HNVQ8,*"];M'6
M94ML-9 JL/[$,X'M.<GEQB;BNZOGCJ4+BS<J6BZO@]-X>,YY-&';;$5B23^[
M%%U/=96<JEW.OJV7B!H8)3M88B)\A(X8O20SEY07,$T%R^"V3'O(6/\!5GO&
M%3V3RP0K>1%77[LCN/VH(]:)\"WS#"256Q(8D(V"D8>(6@6-+Y^E*XL_4: 4
M7V$/+YQ*RJ;&C5I[,7JG$/.1KI>1*O(I(D)>"/W@AGG+4\(*>:IX?#:!G2-A
MA0K5HY"H;"N9K5H1#HK>U<P!"HI9XLS*30K;U1\A'-BOZ]S2J#+_O4WU\G.$
M.*&YS4)B#AN<D 7N9";P7^9>Y72I2K86A2I(C#QF4^.%VW33)$?XE#?E7_.N
MWG&)L;>.V(YJ:B/H$O5"QD]6?5=V,D-TB,6L*+\AU9:E(YED5D%%A["O<NK3
M']EU$+!118E_>51HVCWJG="$;():-Y445.$=*]11FC3"?:>EE.KS""D@$0ZB
ME7(-JR%Z4M[U!(,+IL,#Y?&P8U^0UK,Y+ZMUB>@5%V$XTSB<<UL!@I)Z_04=
M9D*VH(*"0*6  [%G*10P"I7QO5;.7_@V9-]1,E$7%VZUKC@2(TUS?(]0"CJM
MQ.6,7'YE.B,YXP=F_=T.:^F2;%4ICUZ/MD7ZJ1+L'1/'"$\]58T=0]=2N,UA
M!Y&E%?5L>>PF+V!TG<)!A6W BJ7:G00-Q% 4T\*V]JD-;:!^4?-]3:&EH%S/
M!X\ZML?2%L"D"K^VV:"7$H]HS<I'ZTM;2D1W%A(64_NQI<2'# YV;M?H2.!$
M'U?>-+NK!4Y"6#<O;RHE;Z*/*&X^[\M_WX,[PG6^VL-U/@5<YZL]7.>S.(F/
MOSQXLBMC9,?E-+TNJ:L>3Q2NHN'2N&F@7C5A:UKCUW'#DZU]W.1MX0<0*DML
M._1]D?L:P"KQ#.YVJ\=R\Q(790?FMQ)@VH*,==IK&X;RY.'A*$%P1CP<X#^.
ML!Y\@F@(_N]7\M^OY;_?R'\/\4%$3N"_'VU!<S!_[=C3MTNDB?K SA[0#>""
MGZXWQO:4--UF5P\?/Y[ ZWXO^.Y]]_T?X!;<1;''W9Z\D_?(!\]YE(N&8=?E
M!(B=USX3SONZN&3LC?/G-6K"L(%!!UCQ053%Z@K]]NQ]8A>U\9V!/6?M30YR
MN?PX6P"]*O X,08/H5A33@RQI6U$NU]"@V)]EFGUSHD#RPJ)'C0^I5RS1-!N
M6IY8FP1>*(V+T.EJFX;I&^RTQ+&GU.^$3Y&9%7FQ3&?4"F,WL".VC:C5)WQE
M;&%GUFSC8+-J/UG Q3LG$!&2PX!XRXJJLY.?N>ZZBQ)L.Z_0B@<#%OG4$Q)U
M^NS:I0I2QOA<)5)0:H6YH>M<0E"E83=%;[#%$[W!F:6ZIU?IU!Z#RM9J93]%
M78P]B]/)<\E#K=R)8G8,VJ88T!L):5BC2PD<"MJQQ$?!<?/*#H-KAPP'/L1C
MN=9H,#.34D61Z@9%!E)@Q>VZ8R'Z%0[CS)2Y%2 <)1'G.'.SN9\X3&S++>"I
MFKJ$!!\]!:[U/Q3NM,0M<, X-<6(71"#EYQD+QY=+V/%@KM0:<VQ$ZRQ92,A
M,:>RYX4,2PC7JC75RY: E1%2*/Y#Y*&$3ZU L?15:7M!"4593"F?B(MFS+F[
M#7*M9KDTK#,#NEAEI.YV+EXZX\J=K'.%$#6XJ4CWD5+C+MO?;13JR3)Y9S@
MS5%E-0A?F*TKV5=)3R%^W';PF@4-<Y^,-APT@4T6RCQITB U'[PB;Z3@0)L*
MLO6%Z4G%AKE<7\>0A@-UP6 ?TLI>%%TMJ -7$J5:Z6NEZ%R[VT>'PZ!JYE1/
MXAT?GDW+358U\2>27D?JK"\P$=Z2G5VPY)*^"[[&T4RR7_,B?\!TU7@5-X
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ME4"[N4R)R<76>E)T]+^M!]>^ [)BC!13:I\@PU71R(X2ELT"!'XS_ K_$5L
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MO@0RR6EAS^.I,-_K.T9$SSP>N%W;DI/Q\^*5JKOHQH29WYTH80V>5IR69&Q
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M:S$3$T,4+[-JS";$7= #K)F+2C,V@2"('H%;"M$66;(_GDQ?/"UM=]Y<V$_
M,Q]TOA<9E<"P>!?W'\5[2D1\VB!IY)-.A3R2UFT;]ER\-7)>FB>2L5PSAH &
MI%X<89(WXBXWQ[\NP$!&#ZNL-)Z)IC7TEL)TQKG%V:IU-YU=>Q*=I0#P"?Q'
M#)0S5%ZI>=391&%,A*67SE%]W='[$A*FRGDTE_48/5#MZO2B"NA#?VNWTYNJ
MG3 76M1%A'F605![X2:CR+.G-2:</ORIF)]3J7/N#X=B\LMJDO!RDOU8"4IW
M0.:5_H353U@AKT%C2;VB%2-/7R/A-UZUJEI;192D?8Y@3S)RW8ZFQA9D&[K3
MC62/M%S)[A'.)**3:3Q3YL%8\UEA-_$9-9X5U46F/%J"*%C@R$***-:MWMU)
MWZ-/3.'-Y<99[KLGSO(+RDG)"Z!3E^"?&E@3S=!<\,WLM/O?VJ6WNS,X&7[P
M 4,P54"FMX**D-7/F6^>?E#ZGJ3AAZ"XA1$.[L5$#8< P:@0E/#(4_$-I/)
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MW3!A3[@H6-VL7@0Y46XFU'OL[OAVKP35F$UJK34P[Y_P+TB9B[>WA0UY;J]
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M@%2X<MF?9-*>QFC^XSXB/1A.2P[I*BHVQMS2HJS& YLX&U![R9#TV:ES:LG
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MCK!EHHDLN9+,Y>\KV9:Y& C0EB=Y]YRSN]Y=F>;E+"9@@KC C+8LW_$L@&C
M0DS'+>MA:'\=MCL="UQ>O'\'U*_YP;;!-48D;( K%M@=&K%S< MCU #?$44<
M2L;/P2,DJ;:P:TP0!VT6)P1)I!QYI 8X=4X@L.T]9!\1#1E_&'1*V1<I$]%P
MW>ETZE V@5/&7X43L'@_P:&$,A6EFC?SBM]^]!X604G^>,,2]GDVP$]C1+^D
MWT9/2:\/:^T4WLEYO5[K/[_.)O' CP;TYGX>3.K>O O;/=QS'W\^P^<?><BF
M"%Y0#('J!14M2]=7E#<]<1@?NS7/\]VG7G>8X:P<V)@13%\WP?VSLS,W\QIH
M!3D;<6*D3USM'D&!2F7EQ3OPF H):;""#V5)6 ;7W=RY L4;H:<Y%!MHB-9P
M @7.F$U<Y5#X6MT 4V&/(4Q*< 3%*!,M'"M@P645J(SK(%O.$R0V0G/7"N&^
MW[\ML6.:BA&'-,RF,L/Y7DVO%D$QHO*:\?@*13 E*I7?*20XPBBT@(1\C*0>
M,Y'  +VI9Z854LK44*O%*BS:EB1836UI4";=Y09G!-VK]($^J*W:%D2[W393
M5X,%<-BR\N.2G!$,480ISH(7>^0#6V]-JDM5QXS9=-?!5:54H+!/+[)SPI%0
M]*RHKC(4_ *RFQM $J3D*.HBOUW,PFY>9>4=FW4:H AD:]C0 ].R!-;WH%78
M7CB*6I9DC-JFH[]4V8X:* /1$7:L8=:C]3=5!#82D <5E<HUH418@KC$:JJ7
M[H(\=2PU_6XI#-!QA 7<?U@Y@:-#*U<41/YCR5VM7ZVUZ:[NEGI>W[^F*I=Q
M"6AEE7?=I?E7H,N"3&H'13_9AF=KD^W7[!/?F8EPD>DA22S>P&%)&-X126RY
MT3?%%]O@^I"-T+Y!MWP9=@;=R'$1D<)8CDYA^3OR%SED,@<EL=+.4')72VC1
M3[;GJR9N3^<M9O8LCAJ"@*54\ODA@[!,,0_'=6/Q#V"_1AA\W@3]I^#8L$=,
M037XIA%HNKF:.OX!4$L#!!0    ( %.*55N89#;N_0H  '^&   5    =&]O
M;BTR,#(U,3 R,%]L86(N>&ULS9U=;^.X%8;O"_0_L.Y-"XSCB8-=(-G)+C*>
M9&%L-DECSVS;1;&@)<81(I,!)2?VOR\IB;)$\DA*BI*<BQF/^![JI?B8I+Z.
M/_VTVZ3HA? L8?1\='ST<80(C5B<T/7YZ.MB?+&8S><CE.68QCAEE)R/*!O]
M]..?_X3$GT]_&8_154+2^ Q]8=%X3A_8#^@&;\@9^IE0PG'.^ _H&TZW<@N[
M2E+"T8QMGE.2$U%0[O@,?7]T@M%X/*#:;X3&C'^]G]?5/N;Y<W8VF;R^OAY1
M]H)?&7_*CB*V&5;A(L?Y-JMK^[C[6/TIPS^E"7TZDW^M<$:0.%PT.]MER?E(
M[K?:[>O)$>/KR?3CQ^/)/W^]7D2/9(/'"96'+2(C%25KL<4=GYZ>3HI2)364
MNQ5/U3Y.)LI.7;,H33KT#2=9<I85]JY9A/.BUWMW@T"%_-]8R<9RT_AX.CXY
M/MIE\4@=_.((<I:2>_* BF:>Y?MG05*62!!&U;9'3A[L9E+.)S)^0LD:YR26
M.SJ5.SK^7N[HK]7F:[PBZ0A)I> #;-=IJZXJ:.+:[!WA"8LOZ?M<Z]&>[(OO
M#L__AP8TXYTW8<ERG+[+?#/2N>T;\KXC?HAS?Z3%,$_>=Z0;D?\7V[EI^<V'
MUWY<4[GQ6GQJ622[7$Q@)%8F914=(W"QAV)BJ.JN:V=1J]Y4CN:,FVV7,V-1
M9T:BHS5[F<0D$75/OY,?QO)#T6SQGS]F3"P$+E99SG&4JYJ*9IR/+.43W9)4
M7G#E"_.HIW&58A(Q,34]Y^.T/(QE^ -G&^MNJU8S2^$?Z:J.+P^+V 5@M"7C
M)&-;'I$W]4K3+724*D>;5"CDBHK0\=?%Z,="@WY7JO]\FAQJ<=#18@FTW1":
M+T6-EA:TBUUUL\V4ZN5F61"=;#&D][&2(*EQW,$78L>QW/E5BM<6^UJYJRZV
MVE)]W"H,HI-MCO1>KC5(BGQU\Q>213QYELOYKG:T9,X[W6+2Z/N&)BP$3&,P
M"0VMIX']GJP3.;5("_+\ELB-'<,8H'<]]'?:UN<"JS@(:(8X!&>+9A"JHSQQ
M=$'I%J?WY)GQ+GS:,M?4V$SJL#0U03%B,0:B46I1*?9$Q#^VXHR=\'3?"X6A
M=,T%8%5'0Y,%18?=&PA(+??+R))CFB5R .N%Q)0Z/]T S!JG'IHN*$X <_ I
M2:WW2\KBD:2IO!V :?^ 8A.[I@4VK/-B*H,B!K0',E-$H"HD'&PN7^3J7"R3
M!C:VH?<)CV&[BY]:'"Q"NL.!%!5A2,9Y(JEQ&Z*'(4/IFA[ JLZ-)@N*&+LW
MD)52C@J]?T@N:3P(D5KG!Q#-IAV/2A0@'&UG?6@(M4\PKI(LPFGIY4ILRSJ:
M9]&Z!@2TJT-B"(,"!7('PE(&*&:*$*_ _(M@/@R7AM(/+(95.RJU+$!0=&]]
MF$B]%TAF6\Y;KN$9!Y8ZNRG;8[:^/POH@@"EQYQQU[:4MT#Q- -=TCS)]_)Q
MNIOM9D6XI7&FQ!4;D#G%A%X>! N *9V!4H:D#I5"+SVO[A+07#[$"#9'E[DE
MP&ZR34%;$Q )5F, #0=M\4RI%R)F8F3B.)W3F.Q^(7NP78;.+1. S384FB@@
M*NS. "PJ,2K42,B]@'''DPWF^T42]4P5IM M&I#1-ANZ*B X &L '94:+>8S
MGS/)$N_FL0 U>4C*Y\%[* 'U;F'IL=UF!A 'A$ZW0X @$83:43Y!FM.(\6?6
M>-QAQK9B -S/6 RO4'JBW$(UJ EMM#I# @)LB$\ LU;HA_*9%,3D:SQ%!4C6
MX(6XBS@6!RJK_KE.*#D&VV_5NJ6KPVZ;*8LP())@=P _E?*#^H!D#+JEH4 S
M?4-3I_ZAF0Z%9AHT--/W0+-\98% <_*&II[XA^9D*#0G04-S\BYH1,=['6MF
MXN,M7[)7V\/9H-(+,J95*S '67BX&-[Z8)$!<CTC0WQB4BRL;OD=9R\)C> E
M,R3W @Q@VDJ-I@T/';O!/G[J!;&*\SK6E(ORWB^)DOD99=HF[4-,J0D/DK:Q
MWL&E5/M$XHYE.4[_G3QWGHC;Q5[PL!JV0M)2AH>*S5X?,&4,$D$^3JPK7.4-
M#>NK9%JYNU> +;8.KP W"H. P.;(? 6XO'I2BEQWLV24$PR,".UB9YUL,57W
M<:,LC"XV#1D]7'ROA<;'%UEF=TGO'AF%'Q P):YZ&C*G>ELO#Z+' 5-ZKQ<R
M5.@\78V7&28R^_#=*',VL^MVZHE<%031N[H;8YI6Y8Y[\S>>Y&+/,[;9;&EU
ME\?VW""@<]7+G395CUM%0?1^ES.=A$J+VF+'6"Q8FD1)GM#UK^+DDR?8UBJ;
MR!40L$%%@ZD( @70EL[!08B4TC$$=YQ("(GHB.(E0)E8B-\^/%AG^RZQ*RCZ
M#2LX8&40D/3:TV$1 >.H$8'*$%3$^,5FGF5;PM\$CR7$$T*@>0 D0Q\B3I#)
M7JC*0)]L+4BT%?/C_GBZ6B9Y:CNY-"7.YB3 7#TC:>5!L &8TEDHRA![0,?3
MOZW^CE24X^Z_84N.9>[8Q7ZS8BF0?<JJ<@5!AT7%@442! JP+YV&&X8J*2JU
M/K)3M<Q:FJ.5NP+ :DMU?:LPB$ZW.3*^_*V^]C3D7^ZB1V&* "\DV&6NAWZ;
M27WX;VJ"0*##F'%24DF1TOIX(>$P9:W[%P%K;XN =<\B8!WB(F ]=!&P]K8(
M4+LM4X2(<>EVE29K#"0G[%2[AJ+#LLZ'11H4*K _<,RH0] AQG5&RR+%F4S/
MSS?%_J_$!TLK 9VSG)9=-NNDEC91$(QT.3/26I9)YQIB)-6NN=C&24[BTLQ5
M0C&-$IS6Z1%M5\3[0YS1,M!\#4Z//@R&AIDT<"K#5"[#.O"0ZM+UI?3R 8S?
M2)K^0MDK71"<,4KB\EJ*[4Y1M][M$S,]MML/S0#B(' :XA!X=$8&C9]D%%)A
MU94P+R1]8^F6YI@7[Y)SV\@$Z-R2 ]AL$Z.) B+%[@P@I!:C4NWG!>TR>T2]
MR"I_=PAL("1W_+IVIVGMK6VK-B!F.@U"[W!7.3\.:^,RRM,KECF1OQ>1O) O
M.,>5-["]D-SU2Y5=IO6W*6W:@!#J- B^/UG'R%0Q6#'E+64,GXFEUIIU/"6N
MJ=PGCC$LFKEC:DE >-A\=620X4AIO;"PV. T_;S-$DHR>"+25&Y9L%ILL]"2
M!,2"S1? 0B%%2NN%A<L-X6LQO?W,V6O^6.5G!=L&J-VRT6FYS8A5&A K7?X
M9E0(*F-42ET_\.P."<7++(MP2RU2Q]B 9C5F#%U(P$#F#%I2$LGK+3<L1TN&
MOF8$Y8\$758_0]?,!%_6X^N71J)(OA!1KLIIC+D-H2ZQ\U\= 0T;OSUB*(,
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M;V]N7SAK+FAT;5!+ 0(4 Q0    ( %.*55O)5)]:\$$  ..3 0 2
M      "  1HG  !K87)T;V]N7V5X,#0P,2YH=&U02P$"% ,4    " !3BE5;
M=@&0L#U)   ?M@$ $@              @ $Z:0  :V%R=&]O;E]E># T,#(N
M:'1M4$L! A0#%     @ 4XI56W5KY.^V20  .K<! !(              ( !
MI[(  &MA<G1O;VY?97@P-# S+FAT;5!+ 0(4 Q0    ( %.*55N*8AU2Q H
M #PR   2              "  8W\  !K87)T;V]N7V5X,#4P,2YH=&U02P$"
M% ,4    " !3BE5;A+/L@YT*  "P*P  $@              @ &!!P$ :V%R
M=&]O;E]E># U,#(N:'1M4$L! A0#%     @ 4XI56R7CB5S&N0  E"T$ !(
M             ( !3A(! &MA<G1O;VY?97@Q,# Q+FAT;5!+ 0(4 Q0    (
M %.*55MD= ZZ4PT  -$O   2              "  43, 0!K87)T;V]N7V5X
M.3DP,2YH=&U02P$"% ,4    " !3BE5;?3[Z9B@#  #H"P  $0
M    @ ''V0$ =&]O;BTR,#(U,3 R,"YX<V102P$"% ,4    " !3BE5;F&0V
M[OT*  !_A@  %0              @ $>W0$ =&]O;BTR,#(U,3 R,%]L86(N
M>&UL4$L! A0#%     @ 4XI56V)UM*5;!P  V%<  !4              ( !
M3N@! '1O;VXM,C R-3$P,C!?<')E+GAM;%!+!08     "P + ,$"  #<[P$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>kartoon_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="toon-20251020.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
        </entity>
        <period>
            <startDate>2025-10-20</startDate>
            <endDate>2025-10-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-20" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-20" id="Fact000004">0001355848</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-20" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-20" id="Fact000010">2025-10-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-20" id="Fact000011">KARTOON STUDIOS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-20" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-10-20" id="Fact000013">001-37950</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-20" id="Fact000014">20-4118216</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-20" id="Fact000015">190 N. Canon Drive, 4th Fl.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-20" id="Fact000016">Beverly Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-10-20" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-20" id="Fact000018">90210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-10-20" id="Fact000019">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-10-20" id="Fact000020">273-4222</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-10-20" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-20" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-20" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-20" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-10-20" id="Fact000025">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-10-20" id="Fact000026">TOON</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-10-20" id="Fact000027">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-20" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
